• FindZebra
  • About
  • Contact
  • Help
  • Login
Advanced
  • Foot-And-Mouth Disease Wikipedia
    "The Pathogenesis of Foot-and-Mouth Disease II: Viral Pathways in Swine, Small Ruminants, and Wildlife; Myotropism, Chronic Syndromes, and Molecular Virus-Host Interactions". ... WAHID Interface—OIE World Animal Health Information Database Disease card The European Commission for the Control of Foot-and-Mouth Disease (EuFMD) Species Profile - Foot and Mouth Disease , National Invasive Species Information Center, United States National Agricultural Library . v t e Skin infections , symptoms and signs related to viruses DNA virus Herpesviridae Alpha HSV Herpes simplex Herpetic whitlow Herpes gladiatorum Herpes simplex keratitis Herpetic sycosis Neonatal herpes simplex Herpes genitalis Herpes labialis Eczema herpeticum Herpetiform esophagitis Herpes B virus B virus infection VZV Chickenpox Herpes zoster Herpes zoster oticus Ophthalmic zoster Disseminated herpes zoster Zoster-associated pain Modified varicella-like syndrome Beta Human herpesvirus 6 / Roseolovirus Exanthema subitum Roseola vaccinia Cytomegalic inclusion disease Gamma KSHV Kaposi's sarcoma Poxviridae Ortho Variola Smallpox Alastrim MoxV Monkeypox CPXV Cowpox VV Vaccinia Generalized vaccinia Eczema vaccinatum Progressive vaccinia Buffalopox Para Farmyard pox : Milker's nodule Bovine papular stomatitis Pseudocowpox Orf Sealpox Other Yatapoxvirus : Tanapox Yaba monkey tumor virus MCV Molluscum contagiosum Papillomaviridae HPV Wart / plantar wart Heck's disease Genital wart giant Laryngeal papillomatosis Butcher's wart Bowenoid papulosis Epidermodysplasia verruciformis Verruca plana Pigmented wart Verrucae palmares et plantares BPV Equine sarcoid Parvoviridae Parvovirus B19 Erythema infectiosum Reticulocytopenia Papular purpuric gloves and socks syndrome Polyomaviridae Merkel cell polyomavirus Merkel cell carcinoma RNA virus Paramyxoviridae MeV Measles Togaviridae Rubella virus Rubella Congenital rubella syndrome ("German measles" ) Alphavirus infection Chikungunya fever Picornaviridae CAV Hand, foot, and mouth disease Herpangina FMDV Foot-and-mouth disease Boston exanthem disease Ungrouped Asymmetric periflexural exanthem of childhood Post-vaccination follicular eruption Lipschütz ulcer Eruptive pseudoangiomatosis Viral-associated trichodysplasia Gianotti–Crosti syndrome
    FLNA, FSHMD1A, SAT1, SAT2, IFNG, ITGAV, JMJD6, IL15, ATG12, DCTN3, ATG5, G3BP2, BECN1, VTN, VIM, G3BP1, SEC62, EIF2AK3, AKT1, CARD8, SEA, IL23A, DDX56, IL21, NOD2, DHX58, NLRP3, STING1, MIR203A, MIR1307, ST3GAL4, RPL13, CCL20, ANXA13, APCS, ATF4, DDX1, DHODH, EEF1G, EGR1, EIF2S1, EIF4G1, ERN1, FANCG, HLA-B, IL2, ITGA5, ITGB6, ITIH4, RPSA, SH2D1A, NME1, PDR, PPIA, EIF2AK2, ERVW-4
  • Death Anxiety (Psychology) Wikipedia
    PMID 24493652 . v t e Death In medicine Cell death Necrosis Avascular necrosis Coagulative necrosis Liquefactive necrosis Gangrenous necrosis Caseous necrosis Fat necrosis Fibrinoid necrosis Temporal lobe necrosis Programmed cell death AICD Anoikis Apoptosis Autophagy Intrinsic apoptosis Necroptosis Paraptosis Parthanatos Phenoptosis Pseudoapoptosis Pyroptosis Autolysis Autoschizis Eschar Immunogenic cell death Ischemic cell death Pyknosis Karyorrhexis Karyolysis Mitotic catastrophe Suicide gene Abortion Accidental death Autopsy Brain death Brainstem death Clinical death DOA Death by natural causes Death rattle Dysthanasia End-of-life care Euthanasia Lazarus sign Lazarus syndrome Medical definition of death Organ donation Terminal illness Unnatural death Lists Causes of death by rate Expressions related to death Natural disasters People by cause of death Premature obituaries Preventable causes of death Notable deaths by year Unusual deaths Mortality Birthday effect Child mortality Gompertz–Makeham law of mortality Infant mortality Karoshi Maternal death Maternal mortality in fiction Memento mori Micromort Mortality displacement Mortality rate RAMR Mortality salience Perinatal mortality After death Body Stages Pallor mortis Algor mortis Rigor mortis Livor mortis Putrefaction Decomposition Skeletonization Fossilization Preservation Cryopreservation Cryonics Neuropreservation Embalming Maceration Mummification Plastination Prosection Taxidermy Disposal Burial Natural burial Cremation Dismemberment Excarnation Promession Resomation Beating heart cadaver Body donation Cadaveric spasm Coffin birth Death erection Dissection Gibbeting Postmortem caloricity Post-mortem interval Other aspects Afterlife Cemetery Consciousness Customs Crematorium Examination Funeral Grief Intermediate state Internet Mourning Online mourning Obituary Vigil Paranormal Ghosts Near-death experience Near-death studies Necromancy Out-of-body experience Reincarnation research Séance Legal Abortion law Administration Capital punishment Cause of death Civil death Coroner Death-qualified jury Death certificate Declared death in absentia Death row Dying declaration Inquest Legal death Murder Necropolitics Prohibition of death Right to die Suspicious death Trust law Will Fields Forensic pathology Funeral director Mortuary science Necrobiology Post-mortem chemistry Post-mortem photography Taphonomy Biostratinomy Thanatology Other Apparent death Dark tourism Darwin Awards Death and culture Death anniversary Death anxiety Death deity Personification of death Dying-and-rising god Psychopomp Death camp Death drive Death education Death from laughter Death hoax Death knell Death march Death messenger Death notification Death panel Death poem Death pose Death-positive movement Death squad Death threat Death trajectory Dignified death Extinction Fan death Festival of the Dead Fascination with death Hierarchy of death Homicide Last rites Martyr Megadeath Museum of Death Necronym Necrophilia Necrophobia The Order of the Good Death Predation Sacrifice human Suicide Assisted suicide Thanatosensitivity The Goodbye Family Category Outline
    DAP, DNASE1L3, SLC6A4
  • Prosopagnosia Wikipedia
    "First report of prevalence of non-syndromic hereditary prosopagnosia (HPA)" (PDF) . ... Classification D ICD - 10 : R48.8 ICD - 10-CM : R48.3 ICD - 9-CM : 368.16 OMIM : 610382 MeSH : D020238 v t e Symptoms , signs and syndromes associated with lesions of the brain and brainstem Brainstem Medulla (CN 8, 9, 10, 12) Lateral medullary syndrome/Wallenberg PICA Medial medullary syndrome/Dejerine ASA Pons (CN 5, 6, 7, 8) Upper dorsal pontine syndrome/Raymond-Céstan syndrome Lateral pontine syndrome ( AICA ) (lateral) Medial pontine syndrome / Millard–Gubler syndrome / Foville's syndrome ( basilar ) Locked-in syndrome Internuclear ophthalmoplegia One and a half syndrome Midbrain (CN 3, 4) Weber's syndrome ventral peduncle, PCA Benedikt syndrome ventral tegmentum, PCA Parinaud's syndrome dorsal, tumor Claude's syndrome Other Alternating hemiplegia Cerebellum Latearl Dysmetria Dysdiadochokinesia Intention tremor ) Medial Cerebellar ataxia Basal ganglia Chorea Dystonia Parkinson's disease Cortex ACA syndrome MCA syndrome PCA syndrome Frontal lobe Expressive aphasia Abulia Parietal lobe Receptive aphasia Hemispatial neglect Gerstmann syndrome Astereognosis Occipital lobe Bálint's syndrome Cortical blindness Pure alexia Temporal lobe Cortical deafness Prosopagnosia Thalamus Thalamic syndrome Other Upper motor neuron lesion Aphasia
    FGF8, PSEN1
  • Metastasis Wikipedia
    See also [ edit ] Biology portal Medicine portal Abscopal effect Brain metastasis Brown-Séquard syndrome (Sections on cavernous malformation, germinoma, renal cell carcinoma and lung cancer) Collective cell migration Contact normalization Disseminated disease Micrometastasis Mouse models of breast cancer metastasis Positron emission tomography (PET) References [ edit ] ^ "Metastasis", Merriam–Webster online, accessed 20 Aug 2017. ^ "What is Metastasis?" ... Q&A: Metastatic Cancer —from the National Cancer Institute Classification D MeSH : D009362 DiseasesDB : 28954 External resources MedlinePlus : 002260 v t e Overview of tumors , cancer and oncology Conditions Benign tumors Hyperplasia Cyst Pseudocyst Hamartoma Malignant progression Dysplasia Carcinoma in situ Cancer Metastasis Primary tumor Sentinel lymph node Topography Head and neck ( oral , nasopharyngeal ) Digestive system Respiratory system Bone Skin Blood Urogenital Nervous system Endocrine system Histology Carcinoma Sarcoma Blastoma Papilloma Adenoma Other Precancerous condition Paraneoplastic syndrome Staging / grading TNM Ann Arbor Prostate cancer staging Gleason grading system Dukes classification Carcinogenesis Cancer cell Carcinogen Tumor suppressor genes / oncogenes Clonally transmissible cancer Oncovirus Carcinogenic bacteria Misc.
  • Urinary Tract Infection Wikipedia
    In post-menopausal women, sexual activity does not affect the risk of developing a UTI. [4] Spermicide use, independent of sexual frequency, increases the risk of UTIs. [4] Diaphragm use is also associated. [29] Condom use without spermicide or use of birth control pills does not increase the risk of uncomplicated urinary tract infection. [4] [30] Sex Women are more prone to UTIs than men because, in females, the urethra is much shorter and closer to the anus . [31] As a woman's estrogen levels decrease with menopause , her risk of urinary tract infections increases due to the loss of protective vaginal flora . [31] Additionally, vaginal atrophy that can sometimes occur after menopause is associated with recurrent urinary tract infections. [32] Chronic prostatitis in the forms of chronic prostatitis/chronic pelvic pain syndrome and chronic bacterial prostatitis (not acute bacterial prostatitis or asymptomatic inflammatory prostatitis ) may cause recurrent urinary tract infections in males. ... External links Classification D ICD - 10 : N39.0 ICD - 9-CM : 599.0 MeSH : D014552 DiseasesDB : 13657 External resources MedlinePlus : 000521 eMedicine : emerg/625 emerg/626 Patient UK : Urinary tract infection medicine portal v t e Diseases of the urinary tract Ureter Ureteritis Ureterocele Megaureter Bladder Cystitis Interstitial cystitis Hunner's ulcer Trigonitis Hemorrhagic cystitis Neurogenic bladder dysfunction Bladder sphincter dyssynergia Vesicointestinal fistula Vesicoureteral reflux Urethra Urethritis Non-gonococcal urethritis Urethral syndrome Urethral stricture Meatal stenosis Urethral caruncle Any/all Obstructive uropathy Urinary tract infection Retroperitoneal fibrosis Urolithiasis Bladder stone Kidney stone Renal colic Malakoplakia Urinary incontinence Stress Urge Overflow Authority control GND : 4023498-8 LCCN : sh85141416 NDL : 00946940
    CXCR1, SERPINB2, TAC1, TACR1, TLR4, KRT20
  • Exhibitionism Wikipedia
    . ^ John Mollenkopf (January 26, 1967). "Crash Syndrome". The Carletonian . ^ "The Dartmouth Review: The Week in Review" .
    FLNB, USO1, NXF1, SEC14L2
  • Hairy Cell Leukemia Wikipedia
    The presence of additional lymphoproliferative diseases is easily checked during a flow cytometry test, where they characteristically show different results. [16] The differential diagnoses include: several kinds of anemia , including myelophthisis and aplastic anemia , [22] and most kinds of blood neoplasms, including hypoplastic myelodysplastic syndrome , atypical chronic lymphocytic leukemia, B-cell prolymphocytic leukemia , or idiopathic myelofibrosis . [16] Classification [ edit ] When not further specified, the "classic" form is often implied. ... External links [ edit ] Classification D ICD - 10 : C91.4 ICD - 9-CM : 202.4 ICD-O : M9940/3 MeSH : D007943 DiseasesDB : 5589 SNOMED CT : 118613001 External resources MedlinePlus : 000592 eMedicine : med/937 About HCL at the US National Cancer Institute History of HCL and the Godmother of HCL v t e Leukaemias , lymphomas and related disease B cell ( lymphoma , leukemia ) (most CD19 CD20 ) By development/ marker TdT+ ALL ( Precursor B acute lymphoblastic leukemia/lymphoma ) CD5 + naive B cell ( CLL/SLL ) mantle zone ( Mantle cell ) CD22 + Prolymphocytic CD11c+ ( Hairy cell leukemia ) CD79a + germinal center / follicular B cell ( Follicular Burkitt's GCB DLBCL Primary cutaneous follicle center lymphoma ) marginal zone / marginal zone B-cell ( Splenic marginal zone MALT Nodal marginal zone Primary cutaneous marginal zone lymphoma ) RS ( CD15 +, CD30 +) Classic Hodgkin lymphoma ( Nodular sclerosis ) CD20+ ( Nodular lymphocyte predominant Hodgkin lymphoma ) PCDs / PP ( CD38 +/ CD138 +) see immunoproliferative immunoglobulin disorders By infection KSHV ( Primary effusion ) EBV Lymphomatoid granulomatosis Post-transplant lymphoproliferative disorder Classic Hodgkin lymphoma Burkitt's lymphoma HCV Splenic marginal zone lymphoma HIV ( AIDS-related lymphoma ) Helicobacter pylori ( MALT lymphoma ) Cutaneous Diffuse large B-cell lymphoma Intravascular large B-cell lymphoma Primary cutaneous marginal zone lymphoma Primary cutaneous immunocytoma Plasmacytoma Plasmacytosis Primary cutaneous follicle center lymphoma T/NK T cell ( lymphoma , leukemia ) (most CD3 CD4 CD8 ) By development/ marker TdT+ : ALL ( Precursor T acute lymphoblastic leukemia/lymphoma ) prolymphocyte ( Prolymphocytic ) CD30+ ( Anaplastic large-cell lymphoma Lymphomatoid papulosis type A ) Cutaneous MF+variants indolent: Mycosis fungoides Pagetoid reticulosis Granulomatous slack skin aggressive: Sézary disease Adult T-cell leukemia/lymphoma Non-MF CD30 -: Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma Pleomorphic T-cell lymphoma Lymphomatoid papulosis type B CD30 +: CD30+ cutaneous T-cell lymphoma Secondary cutaneous CD30+ large-cell lymphoma Lymphomatoid papulosis type A Other peripheral Hepatosplenic Angioimmunoblastic Enteropathy-associated T-cell lymphoma Peripheral T-cell lymphoma not otherwise specified ( Lennert lymphoma ) Subcutaneous T-cell lymphoma By infection HTLV-1 ( Adult T-cell leukemia/lymphoma ) NK cell / (most CD56 ) Aggressive NK-cell leukemia Blastic NK cell lymphoma T or NK EBV ( Extranodal NK-T-cell lymphoma / Angiocentric lymphoma ) Large granular lymphocytic leukemia Lymphoid+ myeloid Acute biphenotypic leukaemia Lymphocytosis Lymphoproliferative disorders ( X-linked lymphoproliferative disease Autoimmune lymphoproliferative syndrome ) Leukemoid reaction Diffuse infiltrative lymphocytosis syndrome Cutaneous lymphoid hyperplasia Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns with nodular pattern Jessner lymphocytic infiltrate of the skin General Hematological malignancy leukemia Lymphoproliferative disorders Lymphoid leukemias
    BRAF, MAP2K1, CD22, CCND1, TNF, ITGAX, MAP2K7, SOX11, BCL2, CDKN1B, KRT20, CD200, IL2RA, IGH, IGHV4-34, MS4A1, IL6, BTK, TP53, IL2, KLF2, MAPK1, EPHB2, ISG20, CD19, IFNG, IGHV3-69-1, NCAM1, IGHV3OR16-7, ITGAE, ZHX2, MME, IFNA1, NOTCH2, ADA, RAF1, IFNA13, IL1B, CDKN2A, LOC102724971, BCR, RHOH, LOC102723407, FCRL5, CD79B, TBX21, ANXA1, ZNRD2, ABCB6, DCTN6, CIB1, TMED7-TICAM2, NSA2, PCAT1, IGHV3-21, MYMX, BCL2L11, PPP1R13L, GRAP2, DOK2, SYNJ2, SKAP1, ENC1, CLLS2, TICAM2, CD160, IFNL3, RAPH1, IGLJ3, TMED7, IGHV3-30, TGFB1, DBR1, SHC3, IGHV3-33, AICDA, CPAT1, MARCKSL1, PPARGC1A, B3GAT1, WLS, TNFRSF13C, SMUG1, PRAME, ACSBG1, TBC1D9, ALKBH3, IGHV1-2, ABL1, ABCB1, TERC, IL3, IFI27, HLA-DRB1, HEXB, GSTP1, CXCR3, GDF1, FLT3, F2R, ERBB2, CTTN, EGF, CYP19A1, CSF3, CR2, CDKN2B, CD81, CD44, CD40, CD38, CD1D, ATM, APOH, ANXA5, IL1A, IL3RA, TRBV20OR9-2, IL4, SYN2, SPN, ROCK1, RNH1, PTH, PSMD9, PIK3CG, PIK3CD, PIK3CB, PIK3CA, ENPP1, SERPINA5, PAX5, NDUFAB1, MYD88, ABCC1, KMT2A, MCL1, LTA, ITK, ITGB2, IL10, CXCL8, H3P23
    • Hairy Cell Leukemia Gard
      Hairy cell leukemia is a rare, slow-growing cancer of the blood in which the bone marrow makes too many B cells (lymphocytes), a type of white blood cell that fights infection. The condition is named after these excess B cells which look 'hairy' under a microscope. As the number of leukemia cells increases, fewer healthy white blood cells, red blood cells and platelets are produced. The symptoms include a large spleen (splenomegalia) but without an increase of lymph nodes, and general symptoms such as fever, night sweats, fatigue, weight loss. Blood exams show the decreased number of blood cells and platelets. The diagnosis can be made with the biopsy of the bone marrow, blood exams showing antigens that are released by the B-cells.
    • Classic Hairy Cell Leukemia Orphanet
      A rare, slowly progressive, chronic leukemia characterized by presence of abnormal B-lymphocytes (medium sized with abundant irregular pale cytoplasm, hair-like cytoplasmic projections/ruffled cytoplasmic border, a round or bean-shaped nucleus and absent nucleoli) in the blood or bone marrow, spleen and peripheral blood pancytopenia, notable monocytopenia, and marked susceptibility to infection. The characteristic immunophenotype is CD11c+, CD25+, CD103+ and CD123+ with a BRAF mutation in most cases. Epidemiology Classic hairy cell leukemia (HCLc) accounts for 2% of all leukemia cases. Estimates of the annual incidence range between 1/213,000-2,860,000 worldwide. HCLc is observed more commonly in caucasians. Men are predominantly affected with a male:female ratio of 4:1.
    • Hairy Cell Leukemia Mayo_clinic
      Overview Hairy cell leukemia is a cancer of the white blood cells. The white blood cells help fight off germs. There are a few different types of white blood cells. The white blood cells involved in hairy cell leukemia are called B cells. B cells are also called B lymphocytes. In hairy cell leukemia, the body makes too many B cells . The cells don't look like healthy B cells . Instead, they've undergone changes to become leukemia cells. The leukemia cells look "hairy" under a microscope. Hairy cell leukemia cells keep living when healthy cells would die as part of the natural cell life cycle.
  • Tinnitus Wikipedia
    Children with hearing loss have a high incidence of tinnitus, even though they do not express the condition or its effect on their lives. [113] [114] Children do not generally report tinnitus spontaneously and their complaints may not be taken seriously. [115] Among those children who do complain of tinnitus, there is an increased likelihood of associated otological or neurological pathology such as migraine, juvenile Meniere's disease or chronic suppurative otitis media. [116] Its reported prevalence varies from 12% to 36% in children with normal hearing thresholds and up to 66% in children with a hearing loss and approximately 3–10% of children have been reported to be troubled by tinnitus. [117] See also Medicine portal Auditory hallucination Health effects from noise List of people with tinnitus List of unexplained sounds Phantom vibration syndrome Zwicker tone References ^ a b c d Levine, RA; Oron, Y (2015).
    IFNA2, RNR1, BDNF, ARC, ABAT, COCH, CLCNKB, AIFM1, KCNJ5, MPL, MPV17, TMC1, NAGA, PDGFB, SDHB, SDHC, SDHD, SLC12A3, SMARCB1, VHL, DNAH11, FKRP, SLC44A4, KCNQ4, JAK2, MFN2, AFG3L2, DKK1, P2RX2, TUBB6, SLC39A14, STRN4, SUFU, TET2, DIABLO, OSBPL2, NF2, CACNA1A, DSPP, CYP11B2, CYP11B1, CCND1, CACNA1D, TNF, CSF2, LAMC2, SLC17A6, PART1, NT5E, PTPN4, SLC17A7, GDNF, IL2, KCNE3, DCX, SPIN1, CYP2E1, DIAPH1, CRYGD, IL1B, PYCARD, COX8A, COMT, TYMS, CNR1, CNC2, AQP2, ACTG1, ACR, PTCRA, HCCAT5, THEMIS, EPS8, THAS, TRI-AAT9-1, OTC, IL6, IL10, IL1A, KCNE1, HSPA4, KCNQ2, GTF2I, GSTP1, GRM7, GRIN2B, ABR, NHS, GJB2, IL1RN, PEPD, CFP, PRKAR1A, GDF10, GAP43, SLC6A4, SLC8A1, GAD2, SLC18A3, SLC25A1, F11, TCEA1, ERVW-4
    • Tinnitus Mayo_clinic
      Overview Tinnitus is when you experience ringing or other noises in one or both of your ears. The noise you hear when you have tinnitus isn't caused by an external sound, and other people usually can't hear it. Tinnitus is a common problem. It affects about 15% to 20% of people, and is especially common in older adults. Tinnitus is usually caused by an underlying condition, such as age-related hearing loss, an ear injury or a problem with the circulatory system. For many people, tinnitus improves with treatment of the underlying cause or with other treatments that reduce or mask the noise, making tinnitus less noticeable.
  • Postpartum Depression Wikipedia
    Sleep deprivation can lead to physical discomfort and exhaustion, which can contribute to the symptoms of postpartum depression. [39] Risk factors [ edit ] While the causes of PPD are not understood, a number of factors have been suggested to increase the risk: Prenatal depression or anxiety [40] A personal or family history of depression [41] Moderate to severe premenstrual symptoms [42] Stressful life events experienced during pregnancy [43] [44] Postpartum blues [40] Birth-related psychological trauma Birth-related physical trauma History of sexual abuse [45] [46] Childhood trauma [45] [46] [47] Previous stillbirth or miscarriage [42] Formula-feeding rather than breast-feeding [41] Cigarette smoking [41] Low self-esteem [40] Childcare or life stress [40] Low social support [40] Poor marital relationship or single marital status [40] Low socioeconomic status [40] [48] A lack of strong emotional support from spouse, partner, family, or friends [39] Infant temperament problems/ colic [40] Unplanned/unwanted pregnancy [40] Low vitamin D levels [49] [50] Breastfeeding difficulties [51] Administration of labor-inducing medication synthetic oxytocin [34] Of these risk factors a history of depression, and cigarette smoking have been shown to have additive effects. [41] Some studies have found a link with low levels of DHA in the mother. [52] Chronic illnesses caused by neuroendocrine irregularities including irritable bowl syndrome and fibromyalgia typically put individuals at risk for further health complications.
    SLC6A4, TTC9B, HP1BP3, HTR1A, OPRM1, PER2, MTHFR, GABRD, IL10, OXTR, TPO, BDNF, SAGE1, NR3C1, CCN6, ADIPOQ, FHL5, ACOT7, PART1, MARCHF11, AGO2, POTEKP, TAL1, SCLY, ARID4B, KRT88P, CREB3L1, POTEM, COPD, ACTBL2, VSX1, SERPINA3, PRL, ABO, ACTG1, ACTG2, ATP5F1A, OPN1SW, TSPO, SERPINA6, CRH, CRP, EGR3, ESR1, GALR1, GATA3, HPD, HSD11B1, IL6, KRT7, NR3C2, MPI, NPPA, STIN2-VNTR
    • Postpartum Depression Mayo_clinic
      Overview The birth of a baby can start a variety of powerful emotions, from excitement and joy to fear and anxiety. But it can also result in something you might not expect — depression. Most new moms experience postpartum "baby blues" after childbirth, which commonly include mood swings, crying spells, anxiety and difficulty sleeping. Baby blues usually begin within the first 2 to 3 days after delivery and may last for up to two weeks. But some new moms experience a more severe, long-lasting form of depression known as postpartum depression.
  • Hangover Wikipedia
    Potentially dangerous daily activities such as driving a car or operating heavy machinery are also negatively influenced. [5] In mid-2017, it was reported that one company in the UK allows sick days when hung over. [62] Research [ edit ] Psychological research of alcohol hangover is growing rapidly. [ citation needed ] The Alcohol Hangover Research Group had its inaugural meeting in June 2010 as part of the Research Society on Alcoholism (RSA) 33rd Annual Scientific Meeting in San Antonio , Texas , USA. [ citation needed ] In 2012, Éduc'alcool, a Quebec -based non-profit organization that aims to educate the public on the responsible use of alcohol, published a report noting hangovers have long-lasting effects that inhibit the drinker's capabilities a full 24 hours after heavy drinking. [63] See also [ edit ] Auto-brewery syndrome Comedown (drugs) Food drunk References [ edit ] ^ a b c d Stephens R, Ling J, Heffernan TM, Heather N, Jones K (23 January 2008). ... A colorful article on hangovers, their cause and treatment along with reference to famous Soho residents, such as Jeffrey Bernard , Dylan Thomas , and Francis Bacon . v t e Psychoactive substance-related disorder General SID Substance intoxication / Drug overdose Substance-induced psychosis Withdrawal : Craving Neonatal withdrawal Post-acute-withdrawal syndrome (PAWS) SUD Substance abuse / Substance-related disorders Physical dependence / Psychological dependence / Substance dependence Combined substance use SUD Polysubstance dependence SID Combined drug intoxication (CDI) Alcohol SID Cardiovascular diseases Alcoholic cardiomyopathy Alcohol flush reaction (AFR) Gastrointestinal diseases Alcoholic liver disease (ALD): Alcoholic hepatitis Auto-brewery syndrome (ABS) Endocrine diseases Alcoholic ketoacidosis (AKA) Nervous system diseases Alcohol-related dementia (ARD) Alcohol intoxication Hangover Neurological disorders Alcoholic hallucinosis Alcoholic polyneuropathy Alcohol-related brain damage Alcohol withdrawal syndrome (AWS): Alcoholic hallucinosis Delirium tremens (DTs) Fetal alcohol spectrum disorder (FASD) Fetal alcohol syndrome (FAS) Korsakoff syndrome Positional alcohol nystagmus (PAN) Wernicke–Korsakoff syndrome (WKS, Korsakoff psychosis) Wernicke encephalopathy (WE) Respiratory tract diseases Alcohol-induced respiratory reactions Alcoholic lung disease SUD Alcoholism (alcohol use disorder (AUD)) Binge drinking Caffeine SID Caffeine-induced anxiety disorder Caffeine-induced sleep disorder Caffeinism SUD Caffeine dependence Cannabis SID Cannabis arteritis Cannabinoid hyperemesis syndrome (CHS) SUD Amotivational syndrome Cannabis use disorder (CUD) Synthetic cannabinoid use disorder Cocaine SID Cocaine intoxication Prenatal cocaine exposure (PCE) SUD Cocaine dependence Hallucinogen SID Acute intoxication from hallucinogens (bad trip) Hallucinogen persisting perception disorder (HPPD) Nicotine SID Nicotine poisoning Nicotine withdrawal SUD Nicotine dependence Opioids SID Opioid overdose SUD Opioid use disorder (OUD) Sedative / hypnotic SID Kindling (sedative–hypnotic withdrawal) benzodiazepine : SID Benzodiazepine overdose Benzodiazepine withdrawal SUD Benzodiazepine use disorder (BUD) Benzodiazepine dependence barbiturate : SID Barbiturate overdose SUD Barbiturate dependence Stimulants SID Stimulant psychosis amphetamine : SUD Amphetamine dependence Volatile solvent SID Sudden sniffing death syndrome (SSDS) Toluene toxicity SUD Inhalant abuse v t e Headache Primary ICHD 1 Migraine Familial hemiplegic Retinal migraine ICHD 2 Tension Mixed tension migraine ICHD 3 Cluster Chronic paroxysmal hemicrania SUNCT ICHD 4 Hemicrania continua Thunderclap headache Sexual headache New daily persistent headache Hypnic headache Secondary ICHD 5 Migralepsy ICHD 7 Ictal headache Post-dural-puncture headache ICHD 8 Hangover Medication overuse headache ICHD 13 Trigeminal neuralgia Occipital neuralgia External compression headache Cold-stimulus headache Optic neuritis Postherpetic neuralgia Tolosa–Hunt syndrome Other Vascular Authority control GND : 4339907-1
    ALDH2, ACHE, AVP, ELK3, GFER, GJA1, IL6, PDE4D, SGSH, SPAG9, AKR1A1, NCOA6, PANK2, EBPL
    • Hangovers Mayo_clinic
      Overview A hangover is a group of unpleasant signs and symptoms that can develop after drinking too much alcohol. As if feeling awful weren't bad enough, frequent hangovers are also associated with poor performance and conflict at work. As a general rule, the more alcohol you drink, the more likely you are to have a hangover the next day. But there's no magic formula to tell you how much you can safely drink and still avoid a hangover. However unpleasant, most hangovers go away on their own, though they can last up to 24 hours.
  • Arsenic Poisoning Wikipedia
    An experiment of Hu et al. (2002) demonstrated increased binding activity of AP-1 and NF-κB after acute (24 h) exposure to +3 sodium arsenite, whereas long-term exposure (10–12 weeks) yielded the opposite result. [109] The authors conclude that the former may be interpreted as a defense response while the latter could lead to carcinogenesis. [109] As the contradicting findings and connected mechanistic hypotheses indicate, there is a difference in acute and chronic effects of arsenic on signal transduction which is not clearly understood yet. [ citation needed ] Oxidative stress [ edit ] Studies have demonstrated that the oxidative stress generated by arsenic may disrupt the signal transduction pathways of the nuclear transcriptional factors PPARs, AP-1, and NF-κB, [94] [109] [110] as well as the pro-inflammatory cytokines IL-8 and TNF-α. [94] [109] [110] [111] [112] [113] [114] [115] The interference of oxidative stress with signal transduction pathways may affect physiological processes associated with cell growth, metabolic syndrome X, glucose homeostasis, lipid metabolism, obesity, insulin resistance , inflammation, and diabetes-2. [116] [117] [118] Recent scientific evidence has elucidated the physiological roles of the PPARs in the ω- hydroxylation of fatty acids and the inhibition of pro-inflammatory transcription factors (NF-κB and AP-1), pro-inflammatory cytokines (IL-1, -6, -8, -12, and TNF-α), cell4 adhesion molecules (ICAM-1 and VCAM-1), inducible nitric oxide synthase, proinflammatory nitric oxide (NO), and anti-apoptotic factors. [94] [111] [116] [118] [119] Epidemiological studies have suggested a correlation between chronic consumption of drinking water contaminated with arsenic and the incidence of Type 2-diabetes. [94] The human liver after exposure to therapeutic drugs may exhibit hepatic non-cirrhotic portal hypertension, fibrosis, and cirrhosis. [94] However, the literature provides insufficient scientific evidence to show cause and effect between arsenic and the onset of diabetes mellitus Type 2. [94] Diagnosis [ edit ] Arsenic may be measured in blood or urine to monitor excessive environmental or occupational exposure, confirm a diagnosis of poisoning in hospitalized victims or to assist in the forensic investigation in a case of fatal over dosage. ... PMID 21750349 . ^ Joca, L; Sacks, JD; Moore, D; Lee, JS; Sams R, 2nd; Cowden, J (2016). "Systematic review of differential inorganic arsenic exposure in minority, low-income, and indigenous populations in the United States".
    CCL20, AQP9, SKIL, SOD2, SRP68, SSBP1, TRAPPC10, TNF, TNFAIP6, TP53, UBE2E1, PIAS1, USO1, IER3, USP13, CCRL2, CD83, MINPP1, AKAP9, ZNF267, N4BP2L2, RUFY3, TNIK, TRA2A, SOX18, ZFAND6, ZNF331, PELI1, AS3MT, TAF1D, MIR145, SFPQ, CCL3L3, CCL4, ATXN7, CD44, CRP, ERCC1, ERCC3, ERCC4, GOLGA4, CXCL2, CXCL3, HSPA1B, ID2, IL1A, IL1B, IL1RN, INPP5A, KCNJ2, KRT10, MT1A, MTHFR, GADD45B, NDUFB8, PNP, NR4A2, PDE4B, PFKFB3, PTX3, RFX3, RGS1, GSR, ALAD
  • Community-Acquired Pneumonia Wikipedia
    Other immune problems that increase the risk of developing pneumonia range from severe childhood immune deficiencies, such as Wiskott–Aldrich syndrome , to the less severe common variable immunodeficiency . [10] Pathophysiology [ edit ] The symptoms of CAP are the result of lung infection by microorganisms and the response of the immune system to the infection. ... External links [ edit ] Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults PDF v t e Diseases of the respiratory system Upper RT (including URTIs , common cold ) Head sinuses Sinusitis nose Rhinitis Vasomotor rhinitis Atrophic rhinitis Hay fever Nasal polyp Rhinorrhea nasal septum Nasal septum deviation Nasal septum perforation Nasal septal hematoma tonsil Tonsillitis Adenoid hypertrophy Peritonsillar abscess Neck pharynx Pharyngitis Strep throat Laryngopharyngeal reflux (LPR) Retropharyngeal abscess larynx Croup Laryngomalacia Laryngeal cyst Laryngitis Laryngopharyngeal reflux (LPR) Laryngospasm vocal cords Laryngopharyngeal reflux (LPR) Vocal fold nodule Vocal fold paresis Vocal cord dysfunction epiglottis Epiglottitis trachea Tracheitis Laryngotracheal stenosis Lower RT / lung disease (including LRTIs ) Bronchial / obstructive acute Acute bronchitis chronic COPD Chronic bronchitis Acute exacerbation of COPD ) Asthma ( Status asthmaticus Aspirin-induced Exercise-induced Bronchiectasis Cystic fibrosis unspecified Bronchitis Bronchiolitis Bronchiolitis obliterans Diffuse panbronchiolitis Interstitial / restrictive ( fibrosis ) External agents/ occupational lung disease Pneumoconiosis Aluminosis Asbestosis Baritosis Bauxite fibrosis Berylliosis Caplan's syndrome Chalicosis Coalworker's pneumoconiosis Siderosis Silicosis Talcosis Byssinosis Hypersensitivity pneumonitis Bagassosis Bird fancier's lung Farmer's lung Lycoperdonosis Other ARDS Combined pulmonary fibrosis and emphysema Pulmonary edema Löffler's syndrome / Eosinophilic pneumonia Respiratory hypersensitivity Allergic bronchopulmonary aspergillosis Hamman-Rich syndrome Idiopathic pulmonary fibrosis Sarcoidosis Vaping-associated pulmonary injury Obstructive / Restrictive Pneumonia / pneumonitis By pathogen Viral Bacterial Pneumococcal Klebsiella Atypical bacterial Mycoplasma Legionnaires' disease Chlamydiae Fungal Pneumocystis Parasitic noninfectious Chemical / Mendelson's syndrome Aspiration / Lipid By vector/route Community-acquired Healthcare-associated Hospital-acquired By distribution Broncho- Lobar IIP UIP DIP BOOP-COP NSIP RB Other Atelectasis circulatory Pulmonary hypertension Pulmonary embolism Lung abscess Pleural cavity / mediastinum Pleural disease Pleuritis/pleurisy Pneumothorax / Hemopneumothorax Pleural effusion Hemothorax Hydrothorax Chylothorax Empyema/pyothorax Malignant Fibrothorax Mediastinal disease Mediastinitis Mediastinal emphysema Other/general Respiratory failure Influenza Common cold SARS Coronavirus disease 2019 Idiopathic pulmonary haemosiderosis Pulmonary alveolar proteinosis v t e Pneumonia Infectious pneumonias Bacterial pneumonia Viral pneumonia Fungal pneumonia Parasitic pneumonia Atypical pneumonia Community-acquired pneumonia Healthcare-associated pneumonia Hospital-acquired pneumonia Ventilator-associated pneumonia Severe acute respiratory syndrome Pneumonias caused by infectious or noninfectious agents Aspiration pneumonia Lipid pneumonia Eosinophilic pneumonia Bronchiolitis obliterans organizing pneumonia Noninfectious pneumonia Chemical pneumonitis Idiopathic pneumonia syndrome
    CRP, COPD, TNF, IL6, ACE, IL10, HMGB1, MBL2, MMP9, ALB, TLR4, ADM, LNPEP, IRF5, SFTPB, SERPINB6, IL1RN, SLC9A6, HACD1, GRN, SLC2A10, SORBS1, BRD4, CTAA1, ANGPT2, COL4A5, CAP1, AVP, DELEC1, SDC4, NLRP3, SFTPD, SMPD1, TIMP1, TLR9, FGF21, HAVCR1, VDR, ARHGEF5, BHLHE40, BECN1, TIMELESS, SAFB, RGS6, RTN3, CCL18, A2M, RASA1, RARB, AGTR1, AMBP, BAG1, CAMP, CFTR, CHI3L1, DDX3X, FCGR2A, FCN2, HSPA1A, HSPA1B, HSPA2, TNC, IL1B, IL4, CXCL8, IL13, LTA, MCL1, MEFV, MRC1, MUC1, MYLK, SERPINE1, PTX3, MIF
  • Gonorrhea Wikipedia
    Other complications include inflammation of the tissue surrounding the liver , [60] a rare complication associated with Fitz-Hugh–Curtis syndrome ; septic arthritis in the fingers, wrists, toes, and ankles; septic abortion ; chorioamnionitis during pregnancy; neonatal or adult blindness from conjunctivitis ; and infertility . ... Gonorrhea at Curlie "Gonorrhea – CDC Fact Sheet" Classification D ICD - 10 : A54 ICD - 9-CM : 098 MeSH : D006069 DiseasesDB : 8834 External resources MedlinePlus : 007267 eMedicine : article/782913 Patient UK : Gonorrhea v t e Sexually transmitted infections (STI) Bacterial Chancroid ( Haemophilus ducreyi ) Chlamydia , lymphogranuloma venereum ( Chlamydia trachomatis ) Donovanosis ( Klebsiella granulomatis ) Gonorrhea ( Neisseria gonorrhoeae ) Mycoplasma hominis infection ( Mycoplasma hominis ) Syphilis ( Treponema pallidum ) Ureaplasma infection ( Ureaplasma urealyticum ) Protozoal Trichomoniasis ( Trichomonas vaginalis ) Parasitic Crab louse Scabies Viral AIDS ( HIV-1/HIV-2 ) Cancer cervical vulvar penile anal Human papillomavirus (HPV) Genital warts ( condyloma ) Hepatitis B ( Hepatitis B virus ) Herpes simplex HSV-1 & HSV-2 Molluscum contagiosum ( MCV ) General inflammation female Cervicitis Pelvic inflammatory disease (PID) male Epididymitis Prostatitis either Proctitis Urethritis / Non-gonococcal urethritis (NGU) v t e Proteobacteria -associated Gram-negative bacterial infections α Rickettsiales Rickettsiaceae / ( Rickettsioses ) Typhus Rickettsia typhi Murine typhus Rickettsia prowazekii Epidemic typhus , Brill–Zinsser disease , Flying squirrel typhus Spotted fever Tick-borne Rickettsia rickettsii Rocky Mountain spotted fever Rickettsia conorii Boutonneuse fever Rickettsia japonica Japanese spotted fever Rickettsia sibirica North Asian tick typhus Rickettsia australis Queensland tick typhus Rickettsia honei Flinders Island spotted fever Rickettsia africae African tick bite fever Rickettsia parkeri American tick bite fever Rickettsia aeschlimannii Rickettsia aeschlimannii infection Mite-borne Rickettsia akari Rickettsialpox Orientia tsutsugamushi Scrub typhus Flea-borne Rickettsia felis Flea-borne spotted fever Anaplasmataceae Ehrlichiosis : Anaplasma phagocytophilum Human granulocytic anaplasmosis , Anaplasmosis Ehrlichia chaffeensis Human monocytotropic ehrlichiosis Ehrlichia ewingii Ehrlichiosis ewingii infection Rhizobiales Brucellaceae Brucella abortus Brucellosis Bartonellaceae Bartonellosis : Bartonella henselae Cat-scratch disease Bartonella quintana Trench fever Either B. henselae or B. quintana Bacillary angiomatosis Bartonella bacilliformis Carrion's disease , Verruga peruana β Neisseriales M+ Neisseria meningitidis/meningococcus Meningococcal disease , Waterhouse–Friderichsen syndrome , Meningococcal septicaemia M− Neisseria gonorrhoeae/gonococcus Gonorrhea ungrouped: Eikenella corrodens / Kingella kingae HACEK Chromobacterium violaceum Chromobacteriosis infection Burkholderiales Burkholderia pseudomallei Melioidosis Burkholderia mallei Glanders Burkholderia cepacia complex Bordetella pertussis / Bordetella parapertussis Pertussis γ Enterobacteriales ( OX− ) Lac+ Klebsiella pneumoniae Rhinoscleroma , Pneumonia Klebsiella granulomatis Granuloma inguinale Klebsiella oxytoca Escherichia coli : Enterotoxigenic Enteroinvasive Enterohemorrhagic O157:H7 O104:H4 Hemolytic-uremic syndrome Enterobacter aerogenes / Enterobacter cloacae Slow/weak Serratia marcescens Serratia infection Citrobacter koseri / Citrobacter freundii Lac− H2S+ Salmonella enterica Typhoid fever , Paratyphoid fever , Salmonellosis H2S− Shigella dysenteriae / sonnei / flexneri / boydii Shigellosis , Bacillary dysentery Proteus mirabilis / Proteus vulgaris Yersinia pestis Plague / Bubonic plague Yersinia enterocolitica Yersiniosis Yersinia pseudotuberculosis Far East scarlet-like fever Pasteurellales Haemophilus : H. influenzae Haemophilus meningitis Brazilian purpuric fever H. ducreyi Chancroid H. parainfluenzae HACEK Pasteurella multocida Pasteurellosis Actinobacillus Actinobacillosis Aggregatibacter actinomycetemcomitans HACEK Legionellales Legionella pneumophila / Legionella longbeachae Legionnaires' disease Coxiella burnetii Q fever Thiotrichales Francisella tularensis Tularemia Vibrionaceae Vibrio cholerae Cholera Vibrio vulnificus Vibrio parahaemolyticus Vibrio alginolyticus Plesiomonas shigelloides Pseudomonadales Pseudomonas aeruginosa Pseudomonas infection Moraxella catarrhalis Acinetobacter baumannii Xanthomonadaceae Stenotrophomonas maltophilia Cardiobacteriaceae Cardiobacterium hominis HACEK Aeromonadales Aeromonas hydrophila / Aeromonas veronii Aeromonas infection ε Campylobacterales Campylobacter jejuni Campylobacteriosis , Guillain–Barré syndrome Helicobacter pylori Peptic ulcer , MALT lymphoma , Gastric cancer Helicobacter cinaedi Helicobacter cellulitis Authority control GND : 4138035-6 LCCN : sh85055863 NDL : 00569533
    ERBB2, BCL6, SULT2A1, ZAP70, NR3C1, BCL2, SPG21, IRF4, SPACA9, IL6, TLR4, IL10, CD274, MME, PWWP3A, TNF, CXCL8, CFH, NOD2, GKN1, ESR1, VOPP1, LEP, CTNNB1, MET, ABCB1, GPRASP1, CD163, MTA2, SDC1, TP53, MUC16, HOXA10, CDH1, CEACAM3, C4BPA, C4BPB, THEMIS, RD3, CIB2, CKAP5, ZEB2, MIR503, SCO2, HDAC6, MPZL2, NOD1, YAP1, MCRS1, POSTN, CIB1, ATG5, AHCYL1, ARPP21, HSPH1, PPARGC1A, MALT1, MIR489, MIR451A, CKAP4, MIR377, MIR33B, MIR589, MIR371A, VPS9D1-AS1, LOC107987479, TNFAIP3, CCAT2, TP73, TTR, TXN, TYMS, NNT-AS1, UMPS, UVRAG, VDAC1, VIP, XRCC1, MIR1298, MFT2, CUL4B, PPFIA3, TP63, BECN1, URI1, APLN, SQSTM1, SOCS3, PRDM4, SIRT1, GPR182, HAVCR2, IFIH1, FRTS1, FTO, FSD1, MIR195, MIR139, ARHGAP24, FSD1L, BRSK1, HDGFL2, MALAT1, NPVF, WDR20, SOX2-OT, CDCA5, CPXM2, GSC, RASSF6, MLKL, TIGIT, IL27, ADGRF1, MIR200C, TNMD, NID2, MIR224, TFAP2E, RAI14, MIR93, IL22, FOXP3, SOST, TMEM8B, IL17D, LZTFL1, MIR23B, MIR215, CPAT1, SARS2, KIF26B, FBXW7, TLR2, INTS13, MYDGF, MIR214, MIR21, SLC12A9, IL21, ABCA4, SPP1, TGFB2, ERBB4, CYP2D6, DPYD, ATN1, TSC22D3, E2F1, TYMP, EGF, EGFR, EGR1, EMP1, DMTN, ERBB3, ERCC2, CSF3R, FDPS, FES, FKBP5, FOXF1, FOXO1, FLT4, MSTN, GLI2, GNA12, GRN, HINT1, HLA-F, CYLD, CSF3, IFNG, FOXL2, ABO, ADM, ADRB2, AFP, AGER, AHR, AMH, KLK3, ATM, CCND1, CEACAM1, PRDM1, BRCA1, CCR4, CALCR, CAT, CCND2, CD40LG, CD44, CDKN1A, CDKN1B, CDKN1C, CDKN2A, CDX2, CEACAM5, CLU, HMGB1, IGF2, TGFB1, SARS1, PIK3CA, PIK3CB, PIK3CD, PIK3CG, PTCH1, PTH, PTGS2, MOK, RAP1B, RGS3, RPE65, RRM1, CXCL12, SLC26A4, SKP2, SLPI, SNAI2, ABL1, STAT3, TAZ, ZEB1, TRBV20OR9-2, TEAD4, TFF3, TFPI, TFRC, SERPINA1, FURIN, IL2, MATN1, IL15, IL16, IL17A, ILF2, INPPL1, INSRR, IRF1, IRF2, ITGAV, JUN, KIF2A, L1CAM, MAX, NPR2, CD46, MMP8, MMP9, ABCC1, MTHFR, MTRR, MUC4, MUTYH, MYC, NDUFAB1, NFE2L2, NME1, H3P10
    • Gonorrhea Mayo_clinic
      Overview Gonorrhea is a sexually transmitted infection (STI), also known as a sexually transmitted disease (STD). Gonorrhea is caused by a bacterium that infects both males and females. Gonorrhea most often affects the urethra, rectum or throat. In females, gonorrhea can also infect the cervix. Gonorrhea is most commonly spread during vaginal, oral or anal sex. But babies of infected mothers can be infected during childbirth. In babies, gonorrhea most commonly affects the eyes. Abstaining from sex, using a condom if you have sex and being in a mutually monogamous relationship are the best ways to prevent sexually transmitted infections.
  • Lymphoma Wikipedia
    CD5, CD10 , surface Ig Frequently occurs outside lymph nodes, very indolent, may be cured by local excision Nodal marginal zone B cell lymphoma Follicular lymphoma About 40% of lymphomas in adults Small "cleaved" [cleft] cells ( centrocytes ) mixed with large activated cells ( centroblasts ), usually nodular ("follicular") growth pattern CD10 , surface Ig About 72–77% [33] Occurs in older adults, usually involves lymph nodes, bone marrow and spleen, associated with t(14;18) translocation overexpressing Bcl-2 , indolent Primary cutaneous follicle center lymphoma Mantle cell lymphoma About 3 to 4% of lymphomas in adults Lymphocytes of small to intermediate size growing in diffuse pattern CD5 About 50 [34] to 70% [34] Occurs mainly in adult males, usually involves lymph nodes, bone marrow, spleen and GI tract , associated with t(11;14) translocation overexpressing cyclin D1 , moderately aggressive Diffuse large B cell lymphoma , not otherwise specified About 40 to 50% of lymphomas in adults Variable, most resemble B cells of large germinal centers, diffuse growth pattern Variable expression of CD10 and surface Ig Five-year survival rate 60% [35] Occurs in all ages, but most commonly in older adults, may occur outside lymph nodes, aggressive Diffuse large B-cell lymphoma associated with chronic inflammation Epstein–Barr virus-positive DLBCL of the elderly Lymphomatoid granulomatosis Primary mediastinal (thymic) large B-cell lymphoma Intravascular large B-cell lymphoma ALK+ large B-cell lymphoma Plasmablastic lymphoma Primary effusion lymphoma Large B-cell lymphoma arising in HHV8-associated multicentric Castleman's disease Burkitt lymphoma/leukemia < 1% of lymphomas in the United States Round lymphoid cells of intermediate size with several nucleoli, starry-sky appearance by diffuse spread with interspersed apoptosis CD10, surface Ig Five-year survival rate 50% [36] Endemic in Africa, sporadic elsewhere, more common in immunocompromised and children, often visceral involvement, highly aggressive Mature T cell and natural killer (NK) cell neoplasms T-cell prolymphocytic leukemia T-cell large granular lymphocyte leukemia Aggressive NK cell leukemia Adult T-cell leukemia/lymphoma Extranodal NK/T-cell lymphoma, nasal type Enteropathy-associated T-cell lymphoma Hepatosplenic T-cell lymphoma Blastic NK cell lymphoma Mycosis fungoides / Sezary syndrome Most common cutaneous lymphoid malignancy Usually small lymphoid cells with convoluted nuclei that often infiltrate the epidermis, creating Pautrier microabscesseses CD4 5-year survival 75% [37] Localized or more generalized skin symptoms, generally indolent, in a more aggressive variant, Sézary's disease , skin erythema and peripheral blood involvement Primary cutaneous CD30-positive T cell lymphoproliferative disorders Primary cutaneous anaplastic large cell lymphoma Lymphomatoid papulosis Peripheral T-cell lymphoma not otherwise specified Most common T cell lymphoma Variable, usually a mix small to large lymphoid cells with irregular nuclear contours CD3 Probably consists of several rare tumor types, often disseminated and generally aggressive Angioimmunoblastic T cell lymphoma Anaplastic large cell lymphoma Precursor lymphoid neoplasms B-lymphoblastic leukemia/lymphoma not otherwise specified B-lymphoblastic leukemia/lymphoma with recurrent genetic abnormalities T-lymphoblastic leukemia/lymphoma 15% of childhood acute lymphoblastic leukemia and 90% of lymphoblastic lymphoma . [29] : 635 Lymphoblasts with irregular nuclear contours, condensed chromatin, small nucleoli and scant cytoplasm without granules TdT , CD2 , CD7 It often presents as a mediastinal mass because of involvement of the thymus .
    ATM, PRF1, BLM, WAS, BCL2, EZH2, PTEN, CDKN2A, MYD88, MLH1, SH2D1A, KRAS, LIG4, NRAS, CD274, CDKN2B, TP53, FAS, NOTCH1, MTHFR, CDK4, BRAF, TNFAIP3, SOCS1, IKZF1, RHOA, NOTCH2, JAK3, MTR, BCL11B, PON1, EPHX1, MIR143, OGG1, CDK6, MAD1L1, DOCK8, RAC2, TWF1, PTGER4, CSF3R, HMGA1, EPM2A, NFKB1, IGH, BCL10, STAT3, BCL6, MS4A1, CD19, RTEL1, MSH2, MDM2, MAGT1, NBN, CR2, DCLRE1C, RAG2, TNFRSF13B, MSH6, RUNX1, PMS2, NFKB2, ZAP70, XIAP, TNFRSF13C, ADA, RAG1, TP63, CHEK2, ITK, XRCC4, PTPN11, HLA-DRB1, HLA-DQA1, RB1, RECQL4, WIPF1, CASP10, HLA-DQB1, PRKCD, TERT, SPINK1, APC, RAD54B, PNP, DNASE1L3, ICOS, TINF2, IL2RG, NCAM1, IL6, NPM1, MCL1, IL7R, CD81, CXADR, CFTR, PARN, IL10, CD44, CD40LG, CD40, KIF11, MYC, RMRP, TNFRSF8, CSF3, PAX5, PIK3CD, PDCD1, PIK3CG, PIM1, PIK3CB, IL2, DKC1, PIK3CA, PRKAR1A, IFNG, LYST, MAPK1, MME, JAK2, HLA-DRB9, MGMT, CDKN1B, ABCB1, PGM3, PRSS1, IL4, IRF4, H3P10, TNFSF12, NR1I3, USB1, PRMT5, BMI1, TRIM13, CTC1, ZFP91, OR10Q2P, AICDA, BTK, ARHGAP24, TCL1B, PDLIM7, KRT20, RAD54L, BCR, TNFSF13B, TCL1A, WRAP53, NSUN2, ARR3, IGHV3-69-1, IGHV3OR16-7, FOXP1, SMUG1, TBC1D9, NHP2, CTRC, CCND1, NOP10, CHD7, BIRC3, MALT1, ALK, DDX41, LOC102723407, CASR, COMMD3-BMI1, TRBV20OR9-2, TNF, TP73, SPG7, MIR155, TERC, LOC102724971, CXADRP1, VEGFA, ZFP91-CNTF, AKT1, PTGS2, CARD11, CD38, CD79B, STAT5B, PTPRC, CD22, HIF1A, GZMB, TMED7, STAT5A, CD27, H3P23, TICAM2, TMED7-TICAM2, IFI27, IL15, PRL, CASP3, PSMD9, KIT, MIR17HG, PRDM1, ZNRD2, CXCR4, DCTN6, IL2RA, LGALS1, FGFR1, CTNNB1, MIR21, SOAT1, MMP9, NOS2, BRCA2, CDKN1A, REL, TGFB1, CD28, SKP2, SOX11, CXCL12, CD34, GBA, HDAC9, TIAM1, CD79A, IGF1, EPHB2, CBLL2, KMT2A, IL18, TNFSF10, ISG20, PWWP3A, MUL1, PRKN, CREBBP, NOS1, SUB1, NPR2, LYN, BCL2L11, BAX, CIB1, JUNB, RASGRP1, JUN, FCER2, CD99, NME1, LOC105379528, H2AX, MET, NR0B2, HPSE, LAIR1, XRCC1, TIA1, HSP90AA1, LMO2, CDR3, MAPK3, PTPN6, TRAF1, TRAF3, LOC390714, IL3RA, PLK1, SLC16A1, CRK, CCND3, CD70, BRCA1, ABL1, CSF2, AHI1, GCSAM, KMT2D, KLRK1, MAP3K20, ITGAM, DDIT3, JUND, POU2AF1, B2M, TNFSF13, FASLG, MTOR, FBXW7, FOS, CD47, PER2, AIMP2, TNFRSF9, CD80, UCHL1, TIMP1, NR4A1, CD1D, LINC01194, TYK2, POLDIP2, RNF19A, HLA-A, CDK2, AKT2, CASP8, SYK, SIRT1, STAT6, CASP2, FOXP3, AHSA1, TET2, GRAP2, ASRGL1, MAPK14, MUC1, LONP1, ACTB, ETS1, ESR1, CSF1R, ABCB6, HDAC6, PPARG, CTLA4, MYCN, CXCL13, KLRC4-KLRK1, EPHA7, EP300, ENO2, LAMTOR2, PDCD2, IL21R, MYB, CREB1, IL5, DNMT3A, THBS1, PDCD1LG2, STAT1, IL9, ATN1, ERVW-1, IL1B, DLL1, IDH2, IL1A, FCRL4, TCF3, ANPEP, TRG, ATRAID, NXT1, AHR, CCR4, CCR5, MCTS1, TLR7, PTPN2, CD14, BIRC5, MIR150, CFL1, LAMTOR1, CDKN2C, MAP2K1, MDM4, RPSA, CD48, S100A9, PSMB6, RAC1, TPPP2, CD74, MYDGF, CYP1A1, CDC25A, DAPK1, KIR3DL1, MTX1, SF3B6, PDGFRA, PSMB9, SLPI, SLC19A1, NAT2, PDGFRB, DHX9, TNFSF8, CHEK1, APAF1, BCL11A, CD33, ITGB2, ABCC1, CCL5, DCC, CCND2, NCR3LG1, FCGR3A, EGFR, BMP6, EIF4EBP1, CDK2AP2, WT1, XPA, EGR1, YY1, GSTT1, GSTP1, GSTM1, FLT4, GRN, MAFK, TRRAP, GLB1, PHB2, H3P12, BAK1, RPP14, ACVRL1, MRPL28, SERPING1, BCL2L1, FLI1, FLII, TNFRSF14, FOSB, ZNF197, TNFRSF10A, TLX1, HLA-G, ESR2, H3P9, MIR17, EEF1E1, H3P8, UBE2I, TYMS, MIR18A, ERBB2, CARTPT, LXN, PTHLH, CDC42, CDH13, ODC1, GNLY, LIMD1, PTPN1, HERPUD1, PLSCR4, PRLR, CDK9, CDC25B, ANXA5, ROR1, CCR7, RASGRF1, RARA, NLRP2, ALLC, BCL3, DLEC1, CCR6, CTCF, PAG1, NTRK1, NRP1, MVP, CFLAR, CDK1, TNFRSF17, BSG, PRC1, PIAS2, MARCKSL1, CLTA, SERPINA5, PPIG, TBL1XR1, RAPH1, DLC1, CXCR5, CLEC10A, CKS1B, CLTC, SERPINA1, SLC16A3, SLC16A4, ERVK-6, CEL, APOBEC3G, PML, CMA1, BACH2, IL21, CEBPA, CREBZF, MTA1, PRKCB, CDKN2D, SCYL1, WLS, RHOJ, BBC3, BCOR, TNFRSF10B, PART1, BLNK, TAL1, KDM6A, VCAM1, WEE1, MAP3K7, BRD4, CD5, ZFP36, IL22, STAT4, IGK, SST, ZBTB17, ZBTB7A, PHLPP1, ACSBG1, ATR, UCP1, REG1A, SETD2, MCAT, POLM, TPM3, HSP90B1, TLR3, TLR1, TLE1, RUNX2, TIMP2, THY1, TCHH, TRAF6, GNL3, TWIST1, IGKV3-20, TFRC, UCN, SOS1, SOD2, STAB1, SNCA, CCL3, CCL2, SATB1, SAI1, TNFSF11, COPS5, DYNLL1, S100A4, BCL2A1, HPGDS, CASZ1, HRK, RNF2, TNFRSF6B, APOE, BATF3, RET, IL24, PIM2, CCL4, CHP1, SNAP25, IL23A, NR4A3, MLLT10, NINL, CALM3, SLC2A1, IL17D, CALCA, TLR9, SELE, CALM2, SDC1, CALM1, CX3CL1, CCL17, CNR1, NAT1, GSTK1, PARP1, AFP, LBR, STMN1, LAMC2, LAG3, BTLA, DAP, KIR3DL2, KIR2DS1, TMTC3, WG, TXLNA, MIR92A1, ITGA4, IL27, SCFV, CKS1BP7, IRF7, LGALS7, HOTAIR, DNER, FN1, MUC16, CD46, MCM2, GAPDH, NLRP3, LGALS7B, RBM45, CYP2B6, LMNA, GEM, CYP2E1, SLCO6A1, RICTOR, GUCY2D, CXCL9, IL1R1, EGF, MIR19B1, IGKV@, MIR19A, E2F1, IGF2, IFNA13, IFNA1, RCAN1, HOXC5, IAPP, HRAS, HTC2, HSPA5, HSPA4, IGL, IL1RN, IRF5, HLA-DPB1, INPP5D, CXCL10, NQO1, IL13, SERPINA9, CLEC4D, HGF, DLX5, STING1, MIR203A, IL7, DNMT1, DNMT3B, MIR20A, HLA-C, FOXO1, MIR142, BMF, PARP9, ERCC2, ERCC5, NFATC1, CSNK2A2, NEDD9, NEDD8, FH, LINC02605, FGFR3, ERVK-32, EZH1, FGF2, EPAS1, GLIS2, ABO, MYCL, ERVK-20, FCGR3B, SYVN1, MRC1, FCGR2A, F9, MTAP, COX2, H3P13, MTCO2P12, NGF, COX8A, MEF2B, AMH, ADRA2B, EML4, MIR152, BMP4, SUZ12, ADRA1A, ACAP2, HS3ST2, AXL, PRAME, SEC14L2, TMEM97, ATRX, DLEU1, MIR210, ATIC, PATZ1, CBX7, MIR221, ACOX1, ISCU, TFG, MIR222, MIR223, NOMO1, MLYCD, MIR29A, MIR30A, KLF2, MIR7977, H3P19, TP53COR1, PPP1R15A, CD2AP, LOC110806263, SLC23A1, MIR187, PTPN22, MYCBP, IBTK, HSPB8, BRS3, MIR182, GREM1, PIGK, SMC4, LAT, SND1, MIR16-1, MIR200B, MIR197, NAMPT, DICER1, NOCT, SERPINC1, MIR15B, MIR15A, PRPF6, SPRY2, MIR205, CADM1, SLC23A2, SH3BP4, H3P11, EIF3K, ROR1-AS1, MIR320A, CFDP1, ATF7, IGF2BP1, SSX2B, RAB40B, CKAP4, MIR633, FAM72B, SLC27A5, GGTLC5P, IGLL5, MIR31, SOX30, NCF1, INAFM2, SMC2, RBM14-RBM4, ANXA8, UBE2C, TPPP, TMED2, IGF2BP3, ANXA8L1, GGTLC3, GNA13, GGTLC4P, FAM72A, PLK4, CD226, PLK2, HSPH1, ADM, CCR2, CXCR6, FRS2, IGF2BP2, MIR711, BCL2L2, ADAM28, GGT2, HCST, BCL2L2-PABPN1, ANP32B, P3H3, H4C15, TPX2, MIR376A1, TARP, SETX, PIM3, MSE, PARP4, KDM4C, SPART, MIR93, RBM14, RCOR1, MIR34B, MIR34A, KIR2DS2, ATMIN, SMCHD1, ERVK-18, ATF6, CORO1A, MIR494, RASSF1, BGN, PTGDR2, DCTN3, KAT5, BIK, TREX1, STK38, BAD, POU5F1P4, POU5F1P3, RRAS2, IKZF3, IKZF2, MIR193B, NXF1, SEC31A, LINC00273, VOPP1, IGKV1-5, ASS1, FOXP2, NAPRT, TIGAR, RTN4, SCGB3A1, SALL4, MTG1, APEX1, DERL3, CCDC34, DPP9, AHRR, ZNF608, HACE1, PCDH10, WDR48, CXCL16, DIXDC1, TP53INP2, HSH2D, KIF14, PCBP4, UTP3, ACKR3, DIABLO, BIRC2, ATF7IP, CCAR1, DHX32, KRT222, USE1, PBK, H4-16, C10orf90, ALOX15, CHPT1, SLAMF6, CARD16, TIRAP, SPHK2, DBA2, DUSP22, SMYD2, CMTM1, PPP1R14A, ALPI, PLEKHA2, ADGRG7, MAP3K19, CDCA7, SUV39H2, AMELX, PALB2, E2F8, MYH14, CAMKMT, NANOG, DHDDS, DOHH, CCDC51, ANXA1, FCRL5, ST6GALNAC5, RNF34, ELL3, ULBP1, FIP1L1, TRIM11, AMT, MIXL1, RTL10, HAVCR2, AIRE, RIOX2, INSM2, CPAT1, GAS5, PRDM15, KDM2B, TSPYL2, SMOC2, RNASE7, IL25, VTCN1, ALPP, HVCN1, RTN4R, SETD3, CENPM, ASCC2, ABRAXAS1, AMD1, ANXA2, PASD1, ENOSF1, RBM38, RAB7B, ARRB2, LRP12, SLC35B2, SMARCAL1, TSPAN33, ABCB5, GEMIN4, ZC3H12D, F11R, ARRB1, SGPP1, NDUFA13, RDH11, LEF1, PLEKHO1, UBR5, CYP4V2, TRPV2, ARNTL, ISYNA1, SENP1, UHRF1, KCNRG, IGHJ5, IGHV4-59, IGHV4-34, ASCL1, MIR141, IGHV3-52, MIR139, IGHV3-41, MIR127, MIR125A, MIR124-1, STS, IGLV6-57, MIR10B, UOX, JAG1, IGKV3-15, IGKV2-29, MALAT1, ASPG, PYCARD, PGP, ETV7, CTCFL, RC3H1, CLEC4C, DDX53, DDX4, OTUD4, LY6K, NKX2-3, ALOX12, PGPEP1, AQP3, C1orf56, ACSF3, PINX1, IL34, AKIRIN2, NRG4, TMEM176A, TRPV6, CACUL1, IL17RB, NRSN1, MLKL, RHOF, SIRT7, RHOH, NEAT1, NT5DC3, HDAC7, GDE1, NCR3, EEF1AKNMT, NUTM1, TTC41P, WWOX, ADA2, PIMREG, CTAG1A, RIPK4, LNX2, UNC13D, POLE3, TRIM65, KLHDC8B, CRTC2, AR, MAFB, ELANE, TELO2, MKI67, MAOA, MBL2, CX3CR1, MDK, CUX1, MECP2, MEFV, MEN1, CTPS1, MGST1, CIITA, CCN2, MIP, CTAG1B, ITGAL, FOXO4, CSNK2A1, MMP1, MMP3, MMP7, MNDA, MOS, MPL, MPO, MSH3, MST1R, CSF1, MVD, SMAD5, SMAD2, SMAD1, MAD2L1, ITGB1, EIF6, JAK1, GADD45A, ACE, DCK, KCNA3, KDR, KIR2DL4, KLRC1, KLRD1, CD55, KRT8, CYP17A1, LAMP1, LCK, LDHA, LEP, CYP3A4, LGALS3, LGALS9, LRP1, LTA, LTB, LUM, LYL1, CYP1B1, MXI1, MYBL1, CRYZ, PCM1, PCSK1, PCSK2, PDE4A, PDE4B, PDGFA, SERPINF1, PFDN5, PGF, CLU, CHGA, CHD1, CETP, PKNOX1, PLCG2, PLD2, PLG, PLXNA2, PMS1, CEBPB, POMC, POU2F2, POU5F1, PPIA, PPID, PPP1R3A, PREP, CD52, PCNA, PBX1, CRP, PAX3, ATF2, NDUFAB1, NELL1, NF1, NFATC2, CR1, NFKBIA, CPOX, COMT, CNOT2, COL11A2, COL4A3, NOTCH3, NPC1, PLK3, NSF, NT5E, OAS3, ODF1, OPCML, OPRK1, OPRM1, P2RX7, PAEP, PRDX1, PAK1, PAK2, ITGAX, ISL1, PRKDC, GGT1, FLT3, FMOD, FTH1, FYN, G6PD, XRCC6, GAS6, GATA3, EIF4A1, GCG, GCSH, GDNF, GFI1, GH1, DDX6, GH2, GJB2, GNA12, GOT2, GPI, CXCR3, GPR34, GPR42, GPX1, GPX4, GRB2, GRIA3, NR3C1, FLNB, FOXO3, FKBP1AP4, FKBP1AP3, ELF4, ENG, EPHA4, EIF5A, EIF4G2, ERBB4, ERG, ETV5, ETV6, EWSR1, F3, F8, F10, PTK2B, FAU, FBN1, EIF4E, FCGR2B, FCGRT, FES, FGF6, EIF4A2, GPC5, VEGFD, FKBP1A, FKBP1AP1, FKBP1AP2, GRM3, GSK3A, GSK3B, IRF8, ID3, ID4, IDH1, ARID3A, IFNB1, SLC26A3, DPYSL3, DPYD, IGHG3, IKBKB, DPP4, DNTT, DYNC1H1, DNASE1, CXCL8, IL9R, IL10RA, IL12A, IL12B, IL12RB1, IL17A, DES, INSM1, IRAK1, IRF1, IRF3, IRS1, ID1, ICAM3, EIF1AX, ICAM1, EGR3, HBB, HBZ, HCCS, HDAC2, HEXA, HFE, HIC1, UBE2K, HK2, HLA-B, EDNRA, S1PR1, HMBS, HMGB1, HMGB2, HMMR, HNRNPK, TLX2, HPR, HPRT1, HSF1, HSPA1A, HSPA1B, HSPA1L, HSPA2, HTR1A, CDO1, CDKN1C, SNAP91, PICALM, PAX8, CAPN1, RAB7A, CAMLG, KAT6A, RASSF7, PTP4A2, CALR, SLC7A5, COIL, TKTL1, ARID1A, H4C9, GFI1B, TTR, H4C1, H4C4, H4C6, H4C12, H4C11, H4C3, H4C8, H4C2, H4C5, H4C13, H4C14, GPR65, RAE1, BTG2, LAPTM5, ZMYM2, ZNF32, TYRO3, UBC, UBE2B, SUMO1, SLC35A2, UGT1A, UCK2, UNG, UVRAG, VAV1, VCP, CASP9, VEGFC, VHL, VIM, VIP, VWF, CASP7, WNT5A, WRN, XBP1, XBP1P1, ELF3, CASP5, XRCC3, CASP1, ZFX, SLC43A1, CNTNAP1, DGKZ, SLC7A7, FCGR2C, SMC3, LPAR2, IL1RL1, SLC16A7, AURKB, C1QBP, KLF4, COX5A, BUB1B, LPXN, NCR1, ITM2B, MAP4K4, NAPSA, TBPL1, PTGES, BCAR1, CDC42BPB, APOBEC3B, NFE2L3, BUB1, SART3, BTG1, HDAC4, MTSS1, SPATA2, SLC7A6, AIP, USO1, PKD2L1, DDR1, CA12, BECN1, HYAL2, ADAM19, TNFSF14, CA9, FMNL1, TNFSF9, TNFRSF18, DLK1, TNFRSF10C, INPP4B, CES2, CCN4, HDAC3, ALKBH1, DLEU2, NR1I2, SQSTM1, MCM3AP, SGCE, MBD2, PLOD3, NOL3, MAP3K14, SOCS3, TNFRSF4, TTK, MAPK8, SCT, RIT1, CD37, RNASE3, BRD2, ABCE1, RORB, ROS1, RPE65, RPL22, RPS27A, RRBP1, RYR1, S100A8, CCL1, TSG101, CCL19, CCL20, CXCL11, SEL1L, SET, SHBG, SHH, SHMT1, PMEL, SKI, SLAMF1, SLC2A3, SLC7A4, RHEB, RGS13, RGS1, RFC1, MAP2K7, CDK7, RELN, PRTN3, PSMD2, PTGDR, PTGDS, CDH1, PTK2, PTK6, PTK7, PTN, PTPN13, PTPRA, PTPRJ, PTPRO, PVT1, RAD23B, RAD51, RAD51B, RAF1, CD68, CD59, RBL2, RBP1, OPN1LW, RELB, SLC22A2, SMARCA1, SMARCA4, CD247, CD3G, TERF1, TERF2, CD3E, TFAM, TGFA, TGFBR1, TGM2, TH, THOP1, CCNT1, TJP1, TK1, TLE2, TLE3, TLE4, KRIT1, TNFRSF1B, TOP1, TOP2A, RUNX3, TP53BP2, CBFA2T3, NR2C2, TRAF2, CAT, TSN, TRGC1, TRB, SUMO3, TCP1, SUMO2, FSCN1, SNRPN, CD9, SPIB, CD8B, SPINK2, SPN, SPP1, SPTA1, SRC, SRI, TRIM21, SSB, SSTR4, SSX2, ST14, STAT2, CD8A, CD6, SULT1E1, STK4, AURKA, STXBP2, TAT, CNTN2, ZEB1, XPO1
    • Lymphoma Mayo_clinic
      Overview Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The lymphatic system includes the lymph nodes (lymph glands), spleen, thymus gland and bone marrow. Lymphoma can affect all those areas as well as other organs throughout the body. Many types of lymphoma exist. The main subtypes are: Hodgkin's lymphoma (formerly called Hodgkin's disease) Non-Hodgkin's lymphoma What lymphoma treatment is best for you depends on your lymphoma type and its severity. Lymphoma treatment may involve chemotherapy, immunotherapy medications, radiation therapy, a bone marrow transplant or some combination of these.
  • Nonketotic Hyperglycinemia Gene_reviews
    Agents/circumstances to avoid: Valproate, which raises blood and CSF glycine concentrations and may increase seizure frequency; vigabatrin, which has resulted in rapid loss of function when used to treat seizures, particularly in those with attenuated NKH who have West syndrome. Genetic counseling. NKH is inherited in an autosomal recessive manner.
    GLDC, AMT, GCSH, SLC6A9, GLRX5, IRF6, GLYCTK, OCA2, LIAS, GCLC, UGCG, BOLA3, LIPT1, B3GAT1, PTPRC, SURF1, CD19, MAPK8, MAPK3, MGAT1, PSS
    • Neonatal Glycine Encephalopathy Orphanet
      Neonatal glycine encephalopathy is a frequent, usually severe form of glycine encephalopathy (GE; see this term) characterized by coma, apnea, hypotonia, seizure and myoclonic jerks in the neonatal period, and subsequent developmental delay. Epidemiology The prevalence of neonatal glycine encephalopathy is not known. Clinical description Patients develop disease manifestations within the first hours or days of life. Symptoms include progressive lethargy, hypotonia, myoclonic jerks leading to apnea. In the absence of intubation and ventilation, apnea may be fatal. With supportive measures, most patients regain spontaneous respiration and some show improvement in alertness over time.
    • Glycine Encephalopathy Orphanet
      Glycine encephalopathy (GE) is an inborn error of glycine metabolism characterized by accumulation of glycine in body fluids and tissues, including the brain, resulting in neurometabolic symptoms of variable severity. Epidemiology In Finland, an incidence at birth of 1/55,000 is reported and in British Columbia, Canada, 1/63,000, with a calculated carrier rate of 1/125. Clinical description Three forms of GE have been recognized based on the age of onset: neonatal, infantile and atypical glycine encephalopathy (see these terms). Most patients have the life-threatening neonatal form and present mild to severe disease manifestations starting within a few days of birth including lethargy or even coma, hypotonia, hiccups, myoclonic jerks, and breathing/swallowing disorders, with subsequent intellectual deficit, spasticity and intractable seizures. A smaller proportion of patients show developmental delay and generally mild seizures in the infantile period, while others do not develop symptoms until late infancy or adulthood.
    • Atypical Glycine Encephalopathy Orphanet
      A rare form of glycine encephalopathy presenting disease onset or clinical manifestations that differ from neonatal or infantile glycine encephalopathy. Epidemiology The prevalence of atypical glycine encephalopathy is not known. Approximately 20 cases have been reported to date. Clinical description Symptoms are mostly non-specific and are not similar to the severe neurological symptoms observed in neonatal and infantile GE (see these terms). Some patients have milder disease with onset from late infancy to adulthood, while others have rapidly progressive severe disease often of late onset. It also includes patients with transient hyperglycinemia, whose symptoms in neonatal period resemble those of neonatal form.
    • Nonketotic Hyperglycinemia Medlineplus
      Nonketotic hyperglycinemia is a disorder characterized by abnormally high levels of a molecule called glycine in the body (hyperglycinemia). The excess glycine builds up in tissues and organs, particularly the brain. Affected individuals have serious neurological problems. Nonketotic hyperglycinemia has two forms, the severe form and the attenuated form. Both forms usually begin shortly after birth, although in some cases, signs and symptoms can begin in the first few months of life. Only the attenuated form begins later in infancy. The forms are distinguished by the seriousness of the signs and symptoms.
    • Glycine Encephalopathy Omim
      A number sign (#) is used with this entry because mutations in several genes in the mitochondrial glycine cleavage system have been found to cause glycine encephalopathy (GCE), also known as nonketotic hyperglycinemia (NKH). These include the genes encoding P protein (GLDC; 238300), T protein (AMT; 238310), and, in 1 patient, the H protein (GCSH; 238330). Most patients with GCE have a defect in the GLDC gene. Clinical Features Classic Neonatal Form Most patients with GCE have the neonatal phenotype, presenting in the first few days of life with lethargy, hypotonia, and myoclonic jerks, and progressing to apnea, and often to death. Those who regain spontaneous respiration develop intractable seizures and profound mental retardation. In the infantile form of GCE, patients present with seizures and have various degrees of mental retardation after a symptom-free interval and seemingly normal development for up to 6 months.
    • Infantile Glycine Encephalopathy Orphanet
      Infantile glycine encephalopathy is a mild to severe form of glycine encephalopathy (GE; see this term), characterized by early hypotonia, developmental delay and seizures. Epidemiology The prevalence of infantile glycine encephalopathy is not known. Infantile cases are less frequent than the classical neonatal form of GE (neonatal GE; see this term). Clinical description Patients present with infantile-onset seizures and variable psychomotor delay after initially normal development, and often have a relatively long history of hypotonia. Seizures of any type are found in less than half of patients and some develop choreoathetosis.
    • Glycine Encephalopathy Gard
      Glycine encephalopathy is an inherited metabolic disease characterized by abnormally high levels of an amino acid called glycine. Glycine is a chemical messenger that transmits signals in the brain. According to the symptoms the disease onset, glycine encephalopathy may be divided in: Classical neonatal form (most common): Symptoms start within a few days of life and may include poor feeding, lack of energy (lethargy), weak muscle tone (hypotonia ), hiccups, breathing problems, seizures , hiccups, and coma. Infantile form: Symptoms start only after 6 months of age, as intellectual disability, abnormal movements, and behavioral problems Late onset: Symptoms include tightness or stiffness of the legs or arms (spastic diplegia), and vision loss due to a damage of the eye nerve (optic atrophy). Transient form: Symptoms are similar to the classic form, but glycine levels decrease and the symptoms may improve within time. Glycine encephalopathy is caused by changes (mutations) in the AMT , GLDC or GCSH genes which result in a deficiency of the enzyme that break-up the glycine.
  • Friedreich Ataxia Gene_reviews
    Pes cavus is common (55%) but generally causes little problem for affected individuals. Restless leg syndrome is common in individuals with Friedreich ataxia, affecting 32%-50% of individuals in two studies [Frauscher et al 2011]. ... Other early-onset ataxias may be distinguishable by virtue of their characteristic clinical features (see also Ataxia Overview): Ataxia-telangiectasia Ataxias associated with pathogenic variants in mitochondrial DNA (see Mitochondrial Disorders Overview) Behr syndrome (spasticity, ataxia, optic atrophy, and intellectual disability) (OMIM 210000) X-linked sideroblastic anemia and ataxia (OMIM 301310) Marinesco-Sjögren syndrome (cerebellar ataxia, cataracts, intellectual disability, short stature, and delayed sexual development) Deafness-dystonia-optic neuronopathy syndrome Late-onset hexosaminidase A deficiency (ataxia, upper and lower motor neuron disorders, dementia, and psychotic episodes) [Perlman 2002] Two autosomal dominant ataxias with sensory neuropathy – spinocerebellar ataxia type 4 (SCA4) [Flanigan et al 1996] and SCA25 [Stevanin et al 2004] – may present with FRDA-like phenotypes (see Ataxia Overview).
    FXN, NFE2L2, PIP5K1B, ATXN1, GABPA, DLD, EPO, CTCF, PPARGC1A, FTMT, GPAA1, ISCU, APTX, SETX, KIF1B, AHSA1, COG5, AGTR1, MFN2, PCLAF, CRTC1, TJP2, GRAP2, PDLIM1, HDAC3, AIMP2, CIR1, RNF19A, SIRT3, CHMP1B, VTRNA2-1, MIR323A, MIR155, C16orf82, CTCFL, HAMP, JPH3, SLC17A7, ATXN10, TWNK, RNF126, GLRX5, PYCARD, MLH3, POLDIP2, VIM, USP7, TP53, TYMS, TTPA, LY6E, LPA, KCNJ5, KCNC3, IFNG, IFNB1, HSPA9, HFE, GAA, ATN1, TIMM8A, CSF3, MAPK14, CRK, CD34, CASP3, CACNA1A, ATXN3, MLH1, NCF2, SPG7, APOA1, TNNT2, TNNT1, TFRC, TFPI, TEAD1, SRF, ATXN2, PDYN, S100A4, PVALB, PTGS2, MAPK1, PPP2R2B, PPARG, POLG, FTX
    • Friedreich Ataxia Gard
      Friedreich ataxia is an inherited condition that affects the nervous system and causes movement problems. People with this condition develop impaired muscle coordination (ataxia) that worsens over time. Other features include the gradual loss of strength and sensation in the arms and legs, muscle stiffness (spasticity), and impaired speech. Many individuals have a form of heart disease called hypertrophic cardiomyopathy . Some develop diabetes, impaired vision, hearing loss, or an abnormal curvature of the spine (scoliosis).
    • Friedreich Ataxia Orphanet
      Friedreich ataxia (FRDA) is an inherited neurodegenerative disorder classically characterized by progressive gait and limb ataxia, dysarthria, dysphagia, oculomotor dysfunction, loss of deep tendon reflexes, pyramidal tract signs, scoliosis, and in some, cardiomyopathy, diabetes mellitus, visual loss and defective hearing. Epidemiology The prevalence of FRDA in Caucasians is estimated at 1/20,000 to 1/50,000. Clinical description The classical presentation of FRDA begins in childhood or adolescence. General clumsiness and gait ataxia are usually the first signs to appear, often followed by pyramidal signs, upper-limb ataxia and dysarthria. Oculomotor manifestations present early and include fixation instability (square wave jerks) and nystagmus.
    • Friedreich Ataxia 2 Omim
      Description Friedreich ataxia (FRDA) is an autosomal recessive neurodegenerative disorder characterized by progressive gait and limb ataxia with associated limb muscle weakness, absent lower limb reflexes, extensor plantar responses, dysarthria, and decreased vibratory sense and proprioception. Onset is usually in the first or second decade, before the end of puberty (summary by Delatycki et al., 2000). For a general phenotypic description of Friedreich ataxia (FRDA), see FRDA1 (229300), which is caused by mutation in the FXN gene (606829) on chromosome 9q13. Clinical Features Smeyers et al. (1996) reported a nonconsanguineous Spanish family in which 2 adult sibs, a male and a female, had a phenotype consistent with Friedreich ataxia, but linkage excluded the FRDA1 locus on chromosome 9q. The patients had onset of progressive ataxia at ages 10 and 14 years, respectively.
    • Friedreich Ataxia Medlineplus
      Friedreich ataxia is a genetic condition that affects the nervous system and causes movement problems. People with this condition develop impaired muscle coordination (ataxia) that worsens over time. Other features of this condition include the gradual loss of strength and sensation in the arms and legs; muscle stiffness (spasticity); and impaired speech, hearing, and vision. Individuals with Friedreich ataxia often have a form of heart disease called hypertrophic cardiomyopathy, which enlarges and weakens the heart muscle and can be life-threatening. Some affected individuals develop diabetes or an abnormal curvature of the spine (scoliosis ).
    • Friedreich Ataxia 1 Omim
      A number sign (#) is used with this entry because one form of Friedreich ataxia (FRDA1) is caused by mutation in the gene encoding frataxin (FXN; 606829), which has been mapped to chromosome 9q. The most common molecular abnormality is a GAA trinucleotide repeat expansion in intron 1 of the FXN gene: normal individuals have 5 to 30 GAA repeat expansions, whereas affected individuals have from 70 to more than 1,000 GAA triplets (Al-Mahdawi et al., 2006). Description Friedreich ataxia is an autosomal recessive neurodegenerative disorder characterized by progressive gait and limb ataxia with associated limb muscle weakness, absent lower limb reflexes, extensor plantar responses, dysarthria, and decreased vibratory sense and proprioception. Onset is usually in the first or second decade, before the end of puberty. It is one of the most common forms of autosomal recessive ataxia, occurring in about 1 in 50,000 individuals.
  • Neuronal Ceroid Lipofuscinosis Wikipedia
    Retrospectively, these papers disclose that the authors grouped together different types of the syndrome. Furthermore, Batten, at least for some time, insisted that the condition that he described was distinctly different from Tay–Sachs disease , the prototype of a neuronal lysosomal disorder now identified as GM2 gangliosidosis type A.
    TPP1, CLN6, CLN3, CLN8, PPT1, MFSD8, CLN5, ATP13A2, KCTD7, ARSG, CTSD, PPT2, CLCN3, CLCN6, DNAJC5, GRN, FBXL3, NCL, CTSF, ATP5MC1, TARDBP, CAPN3, CLN9, PSAP, CPQ, AGER, TMEM106B, TBCK, SLC39A7, ZDHHC15, CAPN8, TFEB, PPP5C, TAC1, SOD2, CALD1, DPYSL2, GAD1, GAD2, KCNMA1, LGALS1, MAS1, MECP2, TRPM1, PKD1, POLG, POU4F1, APP, MAPK13, SNCA, PRCD
    • Neuronal Ceroid Lipofuscinosis Gard
      Neuronal ceroid lipofuscinosis (NCL) refers to a group of conditions that affect the nervous system. Signs and symptoms vary widely between the forms but generally include a combination of dementia, vision loss, and epilepsy. Although the NCLs were historically classified according to their age of onset and clinical symptoms, the most recent classification system is primarily based on their underlying genetic cause . Most forms are inherited in an autosomal recessive manner; however, autosomal dominant inheritance has been reported in one adult-onset form ( neuronal ceroid lipofuscinosis 4B ). Treatment options are limited to therapies that can help relieve some of the symptoms.
    • Ceroid Lipofuscinosis, Neuronal, 10 Omim
      A number sign (#) is used with this entry because neuronal ceroid lipofuscinosis-10 (CLN10) is caused by homozygous or compound heterozygous mutation in the cathepsin D gene (CTSD; 116840) on chromosome 11p15. Description The neuronal ceroid lipofuscinoses (NCL; CLN) are a clinically and genetically heterogeneous group of neurodegenerative disorders characterized by the intracellular accumulation of autofluorescent lipopigment storage material in different patterns ultrastructurally. The clinical course includes progressive dementia, seizures, and progressive visual failure (Mole et al., 2005). For a discussion of genetic heterogeneity of neuronal ceroid lipofuscinosis, see CLN1 (256730). Clinical Features Steinfeld et al. (2006) identified a patient with cathepsin D deficiency in a group of 25 infants and children with a nonidentified genetic cause of a CLN-like disorder.
    • Congenital Neuronal Ceroid Lipofuscinosis Orphanet
      Congenital neuronal ceroid lipofuscinosis (CNCL) is a severe form of neuronal ceroid lipofuscinosis (NCL; see this term) with onset at birth characterized by primary microcephaly, neonatal epilepsy, and death in early infancy. Epidemiology It is a rare form of NCL with only around 10 cases reported in the literature so far. Clinical description Patients present with postnatal respiratory insufficiency, seizures immediately after birth and a lower than normal head circumference. The seizure activity may be noted before birth as unusually strong fetal movements. Etiology CNCL is transmitted in an autosomal recessive manner and is caused by mutations in the CTSD gene (designated CLN10 ; 11p15.5) encoding the lysosomal enzyme cathepsin D.
    • Neuronal Ceroid Lipofuscinosis Orphanet
      Neuronal ceroid lipofuscinoses (NCLs) are a group of inherited progressive degenerative brain diseases characterized clinically by a decline of mental and other capacities, epilepsy, and vision loss through retinal degeneration, and histopathologically by intracellular accumulation of an autofluorescent material, ceroid lipofuscin, in the neuronal cells in the brain and in the retina. Epidemiology The exact prevalence and incidence of this group of disorders are unknown. Clinical description The clinical presentation varies widely between forms but the clinical hallmark is a combination of dementia, visual loss, and epilepsy. Manifestations may begin between the neonatal period and young adult age depending on the form, leading to the original classification of NCLs by age at onset into congenital, infantile, late infantile, juvenile and adult NCL subgroups (see these terms). A Northern epilepsy variant (progressive epilepsy-intellectual deficit, Finnish type; see this term), in which the visual problems may be absent or be mild and go unrecognized, has also been described.
  • Glycogen Storage Disease Ii Omim
    Francesconi and Auff (1982) described Wolff-Parkinson-White syndrome (194200) and second-degree atrioventricular block in a patient with the adult form of glycogenosis II. ... INHERITANCE - Autosomal recessive HEAD & NECK Ears - Hearing loss Mouth - Macroglossia CARDIOVASCULAR Heart - Cardiomegaly - Shortened P-R interval on EKG - Huge QRS complexes - Wolf-Parkinson-White syndrome Vascular - Cerebral artery aneurysm RESPIRATORY - Respiratory failure due to muscle weakness - Dyspnea - Respiratory infections CHEST Ribs Sternum Clavicles & Scapulae - Diaphragmatic paralysis ABDOMEN Liver - Hepatomegaly Spleen - Splenomegaly MUSCLE, SOFT TISSUES - Weakness - Proximal muscle weakness - Myopathic pattern on EMG - Firm muscles NEUROLOGIC Central Nervous System - Hypotonia - Abnormal brain myelination Peripheral Nervous System - Absent deep tendon reflexes METABOLIC FEATURES - Fever of central origin LABORATORY ABNORMALITIES - Elevated serum creatine kinase - Elevated AST and LDH, especially infantile-onset - Presence of vacuoles on muscle biopsy - Deficiency of alpha-1,4-glucosidase (acid maltase) MISCELLANEOUS - Two presentations - rapid, fatal disorder of infancy and slowly progressive muscular disorder of childhood - Patients with later onset have better prognosis - Incidence of 1 in 40,000 infants worldwide MOLECULAR BASIS - Caused by mutation in the alpha-1,4-glucosidase gene (GAA, 606800.0002 ) ▲ Close
    GAA, TNNT2, SI, VEGFA, HTRA1, CFH, MGAM, ARMS2, AMD1, AMD1P2, KDR, PLXNA2, APOE, CCL2, SERPINF1, PGF, CFB, RPE, CRP, CCR2, FLT1, PRKAG2, ELN, ELF3, IGF2R, G6PC, CX3CR1, C3, SKIV2L, IL10, HMCN1, SOD1, SOD2, IL6, TFEB, PON1, MAN2B1, SERPING1, GLA, NFE2L2, IGF1, AAVS1, ACE, IDUA, ELOVL4, TNF, TLR3, RIPK1, FZD4, NELFE, CXCL12, SLC6A8, VLDLR, CXCR4, ZFP36, VWF, TFR2, VIM, UGT1A, TTR, STC1, TRAF6, TNXB, STBD1, TIMP3, NAT2, CFHR4, ADIPOQ, PLEKHA1, UGT1A5, UGT1A9, UGT1A4, UGT1A1, UGT1A3, CCDC40, APOM, PNPLA2, SLURP1, FKBPL, ABCG1, CIAO3, ARMC9, ACAD10, COL18A1, NLRP3, C1QTNF5, ASPM, TEC, C20orf181, UGT1A6, UGT1A7, UGT1A8, UGT1A10, SEMA3E, ATP6AP2, AKR1A1, ARIH2, CXCL13, SLCO1B1, CXCL6, PPARGC1A, KERA, IKZF2, DKK1, SLC16A8, SLC17A5, HPLH1, HPGDS, TBK1, PIK3R4, ANGPTL4, DDIT4, CXCL5, NPPB, CCL11, RYR1, CNTF, COL8A1, CP, CPT2, DES, DHFR, NQO1, EPO, ERCC6, F2, F10, EFEMP1, FCGR3A, FCGR3B, FECH, FHL1, FN1, CCR3, CCR1, CETP, ANG, ACTB, ACTN3, ADM, PARP1, AGL, AHR, ALB, ANPEP, CD59, XIAP, APOA1, APRT, ARSB, BDNF, CALCR, CALR, FPR1, FUT1, GALC, ND5, LRP5, MAP2, MFAP1, MFGE8, CXCL9, MME, MMP9, MYP2, LIPC, NGF, SERPINA1, PPARA, PPARG, MAPK3, RAD51B, PRPH2, LPA, LAMP2, GAS6, CFHR2, GBE1, MSTN, SFN, CXCL1, GSTP1, GSTZ1, GYG1, HIF1A, ITGAM, IDS, CFI, IGFALS, IL1B, CXCL8, IL17A, CXCL10, LINC01672
    • Pompe Disease Gene_reviews
      Gastrointestinal symptoms similar to those reported in patients with irritable bowel syndrome may be underreported in this population and may undermine quality of life.
    • Pompe Disease Medlineplus
      Pompe disease is an inherited disorder caused by the buildup of a complex sugar called glycogen in the body's cells. The accumulation of glycogen in certain organs and tissues, especially muscles, impairs their ability to function normally. Researchers have described three types of Pompe disease, which differ in severity and the age at which they appear. These types are known as classic infantile-onset, non-classic infantile-onset, and late-onset. The classic form of infantile-onset Pompe disease begins within a few months of birth.
    • Glycogen Storage Disease Due To Acid Maltase Deficiency Orphanet
      A rare lysosomal storage disease characterized by lysosomal accumulation of glycogen particularly in skeletal, cardiac, and respiratory muscles, as well as the liver and nervous system, due to acid maltase deficiency. The clinical spectrum comprises infantile-onset disease with severe hypertrophic cardiomyopathy, generalized muscle weakness, poor feeding and failure to thrive, and respiratory insufficiency, and late-onset disease manifesting before or after twelve months of age without cardiomyopathy, with proximal muscle weakness and respiratory insufficiency.
    • Glycogen Storage Disease Type 2 Gard
      Glycogen storage disease type 2 , also known as Pompe disease or acid maltase deficiency disease, is an inherited metabolic disorder. While glycogen storage disease type 2 is a single disease, it may be classified in 2 forms according to the rates of disease progression, its severity and the age at which symptoms start. The classic infantile-onset starts before 12 month of age and involves the heart muscle (myocardiopathy). The later-onset form may start before 12 months of age (non-classic infantile-onset), or after 12 months of age, but does not affect the heart. Muscle weakness is a main symptom in all forms. The infantile-onset is the most severe form and, if untreated, it may lead to death from heart failure in the first year of life.
  • Monoclonal B-Cell Lymphocytosis Wikipedia
    Individuals with high-count MBL (studies based primarily on the CLL/SLL phenotype) are at an increased risk for developing: 1) cancers of the breast, lung, and gastrointestinal tract in up to 13% of all cases; 2) autoimmune hemolytic anemia and immune thrombocytopenic purpura ; 3) unexplained kidney disease as manifested by chronic kidney disease and/or the nephrotic syndrome ; and 4) serious infections. [2] While earlier studies suggested that only very high-count MBL (i.e. >10x10 9 B-cells/L) was associated with a decrease in survival, [2] more recent studies indicate that high-count MBL (i.e. ... PMID 16042682 . v t e Leukaemias , lymphomas and related disease B cell ( lymphoma , leukemia ) (most CD19 CD20 ) By development/ marker TdT+ ALL ( Precursor B acute lymphoblastic leukemia/lymphoma ) CD5 + naive B cell ( CLL/SLL ) mantle zone ( Mantle cell ) CD22 + Prolymphocytic CD11c+ ( Hairy cell leukemia ) CD79a + germinal center / follicular B cell ( Follicular Burkitt's GCB DLBCL Primary cutaneous follicle center lymphoma ) marginal zone / marginal zone B-cell ( Splenic marginal zone MALT Nodal marginal zone Primary cutaneous marginal zone lymphoma ) RS ( CD15 +, CD30 +) Classic Hodgkin lymphoma ( Nodular sclerosis ) CD20+ ( Nodular lymphocyte predominant Hodgkin lymphoma ) PCDs / PP ( CD38 +/ CD138 +) see immunoproliferative immunoglobulin disorders By infection KSHV ( Primary effusion ) EBV Lymphomatoid granulomatosis Post-transplant lymphoproliferative disorder Classic Hodgkin lymphoma Burkitt's lymphoma HCV Splenic marginal zone lymphoma HIV ( AIDS-related lymphoma ) Helicobacter pylori ( MALT lymphoma ) Cutaneous Diffuse large B-cell lymphoma Intravascular large B-cell lymphoma Primary cutaneous marginal zone lymphoma Primary cutaneous immunocytoma Plasmacytoma Plasmacytosis Primary cutaneous follicle center lymphoma T/NK T cell ( lymphoma , leukemia ) (most CD3 CD4 CD8 ) By development/ marker TdT+ : ALL ( Precursor T acute lymphoblastic leukemia/lymphoma ) prolymphocyte ( Prolymphocytic ) CD30+ ( Anaplastic large-cell lymphoma Lymphomatoid papulosis type A ) Cutaneous MF+variants indolent: Mycosis fungoides Pagetoid reticulosis Granulomatous slack skin aggressive: Sézary disease Adult T-cell leukemia/lymphoma Non-MF CD30 -: Non-mycosis fungoides CD30− cutaneous large T-cell lymphoma Pleomorphic T-cell lymphoma Lymphomatoid papulosis type B CD30 +: CD30+ cutaneous T-cell lymphoma Secondary cutaneous CD30+ large-cell lymphoma Lymphomatoid papulosis type A Other peripheral Hepatosplenic Angioimmunoblastic Enteropathy-associated T-cell lymphoma Peripheral T-cell lymphoma not otherwise specified ( Lennert lymphoma ) Subcutaneous T-cell lymphoma By infection HTLV-1 ( Adult T-cell leukemia/lymphoma ) NK cell / (most CD56 ) Aggressive NK-cell leukemia Blastic NK cell lymphoma T or NK EBV ( Extranodal NK-T-cell lymphoma / Angiocentric lymphoma ) Large granular lymphocytic leukemia Lymphoid+ myeloid Acute biphenotypic leukaemia Lymphocytosis Lymphoproliferative disorders ( X-linked lymphoproliferative disease Autoimmune lymphoproliferative syndrome ) Leukemoid reaction Diffuse infiltrative lymphocytosis syndrome Cutaneous lymphoid hyperplasia Cutaneous lymphoid hyperplasia with bandlike and perivascular patterns with nodular pattern Jessner lymphocytic infiltrate of the skin General Hematological malignancy leukemia Lymphoproliferative disorders Lymphoid leukemias
    NOTCH2, KRT20, MS4A1, LOC102724971, IGH, MBL2, LOC102723407, IGHV3OR16-7, IGHV3-69-1, CD19, LEF1, ITGA4, NOTCH1, IGF2BP1, IL22, MBL3P, CD274, IL21, AICDA, XPO1, HM13, CLEC12A, IMMP1L, MIR155, MIR15A, MIR21, LINC01672, COLEC10, BCL2, VIM, TP53, CXCR5, CD22, CD38, CD79B, CDK6, CCR6, IL2, IMPA1, JAK2, LAIR1, MME, NTF3, PIK3C2B, SELL, SIM1, BCL6, TNF, SPN
  • Fish Allergy Wikipedia
    . ^ a b Ridolo E, Martignago I, Senna G, Ricci G (October 2016). "Scombroid syndrome: it seems to be fish allergy but... it isn't". ... External links [ edit ] Classification D ICD - 10 : T78.0 , T78.1 , L23.6 , L27.2 , Z91.0 v t e Allergic conditions Respiratory system Allergic rhinitis (hay fever) Asthma Hypersensitivity pneumonitis Eosinophilic pneumonia Eosinophilic granulomatosis with polyangiitis Allergic bronchopulmonary aspergillosis Farmer's lung Laboratory animal allergy Skin Angioedema Urticaria Atopic dermatitis Allergic contact dermatitis Hypersensitivity vasculitis Blood and immune system Serum sickness Circulatory system Anaphylaxis Digestive system Coeliac disease Eosinophilic gastroenteritis Eosinophilic esophagitis Food allergy Egg allergy Milk intolerance Nervous system Eosinophilic meningitis Genitourinary system Acute interstitial nephritis Other conditions Drug allergy Allergic conjunctivitis Latex allergy v t e Hypersensitivity and autoimmune diseases Type I / allergy / atopy ( IgE ) Foreign Atopic eczema Allergic urticaria Allergic rhinitis (Hay fever) Allergic asthma Anaphylaxis Food allergy common allergies include: Milk Egg Peanut Tree nut Seafood Soy Wheat Penicillin allergy Autoimmune Eosinophilic esophagitis Type II / ADCC IgM IgG Foreign Hemolytic disease of the newborn Autoimmune Cytotoxic Autoimmune hemolytic anemia Immune thrombocytopenic purpura Bullous pemphigoid Pemphigus vulgaris Rheumatic fever Goodpasture syndrome Guillain–Barré syndrome " Type V "/ receptor Graves' disease Myasthenia gravis Pernicious anemia Type III ( Immune complex ) Foreign Henoch–Schönlein purpura Hypersensitivity vasculitis Reactive arthritis Farmer's lung Post-streptococcal glomerulonephritis Serum sickness Arthus reaction Autoimmune Systemic lupus erythematosus Subacute bacterial endocarditis Rheumatoid arthritis Type IV / cell-mediated ( T cells ) Foreign Allergic contact dermatitis Mantoux test Autoimmune Diabetes mellitus type 1 Hashimoto's thyroiditis Multiple sclerosis Coeliac disease Giant-cell arteritis Postorgasmic illness syndrome Reactive arthritis GVHD Transfusion-associated graft versus host disease Unknown/ multiple Foreign Hypersensitivity pneumonitis Allergic bronchopulmonary aspergillosis Transplant rejection Latex allergy (I+IV) Autoimmune Sjögren syndrome Autoimmune hepatitis Autoimmune polyendocrine syndrome APS1 APS2 Autoimmune adrenalitis Systemic autoimmune disease
    PVALB, AGXT, SERPING1
  • ←
  • 1
  • 2
  • ...
  • 554
  • 555
  • 556
  • 557
  • →

FindZebra

contact@findzebra.com